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SUMMARY
The immune system matures progressively from infancy to adulthood, thus children may 
differ from adults in their immune function. The immature immune system demonstrates a 
higher naive to memory T cell ratio, defective macrophage function and antigen presentation 
which, cumulatively, results in diminished production of cytokines such as IFN-y. This 
cytokine has been shown to play a pivotal role in protection against Mycobacterium 
tuberculosis (M. tuberculosis) disease. Other cytokines, such as IL-12 and TNF-a, are also 
involved in the defence against M. tuberculosis. Epidemiological evidence suggests an age- 
related incidence of tuberculosis (TB) irrespective of prevalence in a given region. Reports in 
the literature also demonstrate depressed immune responses in TB patients, at diagnosis, 
(before TB therapy) with subsequent improvement after TB therapy.
The aims of this study were to optimise a whole blood assay in order to characterise immune 
responses, as measured by proliferation and cytokine production, in TB patients (after TB 
therapy) and healthy controls o f different ages. Immune responses of TB patients would also 
be compared, before, and after TB therapy.
A total o f 68 subjects were included in this study. These comprised 27 TB patients and 41 
healthy Mantoux positive controls. All subjects were stratified into two age groups: <12 years 
and >12 years.
Diluted whole blood was cultured and stimulated with the mitogen, phytohaemagglutinin 
(PHA) and the specific mycobacterial antigen, purified protein derivative (PPD) to measure 
proliferation and IFN-y, IL-2, TNF-a and IL-10 production in the supernatant of cultures.
Age was a significant variable for the following PHA-stimulated cytokines: IFN-y, TNF-a 
and IL-10. Proliferation and IL-2 production after PHA stimulation did not demonstrate any 
relationship with age. None of the PPD-stimulated proliferative or cytokine responses 
demonstrated any correlation with age.
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Concentrations of PHA- and PPD-induced IFN-y for all subjects (patients and controls) were 
increased “after therapy”, compared to “before therapy”. This phenomenon could possibly be 
due to maturation in the capacity o f the immune system to produce this cytokine.
Patients >12yrs demonstrated improvement in all proliferative and cytokine responses 
(except for PPD-induced IL-2 and TNF-a) “after therapy”, compared to “before therapy”. 
This is probably a valid finding and is thus in accordance with the literature.
The whole blood assay is a simple, non-laborious assay that, according to the literature, 
produces results that seem to correlate well with that o f conventionally used PBMCs.
Age appears to be an important variable in the quantitative assessment of cellular immune 
responses (when the mitogen, PHA is used as a stimulant) and immune responses of older TB 
patients appear to improve after TB therapy, compared to before TB therapy.
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OPSOMMING
Die immuunsisteem matureer stelselmatig van kind na volwassene. Dus sal kinders se 
immuniteit verskil van volwassenes s’n. Die immature immuunsisteem het ‘n hoer nai'witeit 
vir geheue T-sel verhouding, defektiewe makrofaag funksie en antigeen presentering wat 
gesamentlik lei tot verminderde produksie van sitokiene soos byvoorbeeld IFN-y. Daar is 
bewys dat hierdie sitokien ‘n deurslaggewende rol speel in die beskerming teen 
Mycobacterium tuberculosis (M. tuberculosis). Ander sitokiene, soos IL-12 en TNF-a speel 
ook ‘n rol in die beskerming teen M. tuberculosis. Epidemiologiese data dui aan dat daar ‘n 
ouderdomverwante insidensie van tuberkulose (TB) is sonder dat dit beinvloed word deur die 
voorkoms van TB in ‘n sekere area. Verslae in die literatuur wys ook op onderdrukte 
immuniteitrespons in TB-pasiente by diagnose (voor TB-behandeling) met uiteindelike 
verbetering na TB-behandeling.
Die doel van hierdie studie was om ’n volbloed metode te optimaliseer in ’n poging om die 
immuunrespons te karakteriseer soos gemeet met behulp van proliferasie en sitokien 
produksie by TB-pasiente (na TB-behandeling) en gesonde kontrole persone van verskillende 
ouderdomme. Die immuunrespons van TB-pasiente word ook vergelyk voor en na TB- 
behandeling.
‘n Totaal van 68 gevalle is vir die studie gebruik. Dit sluit in 27 TB-pasiente en 41 gesonde 
Mantoux positiewe kontroles. A1 die gevalle is in twee ouderdomsgroepe verdeel: <12 jaar 
en >12 jaar.
Kulture is gemaak van verdunde volbloed en gestimuleer met phytohaemaglutinin (PHA) en 
gesuiwerde proteien derivaat (purified protein derivative-PPD) om proliferasie en IFN-y, IL-
2, TNF-a en IL-10- produksie in die supernatant van die kulture te meet.
Ouderdom was ‘n beduidende veranderlike vir die volgende PHA-gestimuleerde sitokiene: 
IFN-y, TNF- a  en IL-10. Daar was geen korrelasie tussen proliferasie en IL-2-produksie na 
PHA-stimulasie aan die een kant en ouderdom aan die ander kant nie. Geen van die PPD- 
gestimuleerde proliferasie response of sitokien response het enige korrelasie met ouderdom 
getoon nie.
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Konsentrasies van PHA- en PPD-geinduseerde IFN-y vir alle gevalle (pasiente en kontrole) 
was verhoog “na behandeling”, vergeleke met “voor behandeling”. Hierdie fenomeen kan 
moontlik toegeskryf word aan maturasie in die vermoe van die immuunsisteem om sitokiene 
te vervaardig.
Pasiente >12 jaar het bewyse getoon van verbetering in alle proliferasie en sitokien response 
(behalwe vir PPD-gei'nduseerde IL-2 en TNF-a) “na behandeling”, vergeleke met “voor 
behandeling”. Dit is waarskynlik ‘n geldige bevinding en is dus in ooreenstemming met 
verslae in die literatuur.
Die volbloed metode is ‘n eenvoudige metode wat nie baie arbeidsintensief is nie, wat 
volgens die literatuur, resultate lewer wat goed korreleer met die konvensionele gebruik van 
perifere bloed mononukliere selle (PBMC’s).
Dit wil voorkom asof ouderdom ‘n belangrike veranderlike is in die kwantitatiewe 
beoordeling van sellulere immuunrespons (wanneer PHA gebruik word as ‘n stimulant), en 
of die immuunrespons van ouer TB-pasiente verbeter na TB-behandeling in vergeleke met 
die respons voor TB-behandeling.
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1CHAPTER 1 
INTRODUCTION 
1.1 IMMUNOBIOLOGY OF THE IMMUNE SYSTEM
The human body is constantly besieged by a multitude of microbes, which include bacteria, 
viruses, fungi and parasites. Healthy individuals protect themselves against the replication 
and spread of these microbes by means of their immune system. Immunity to microbes is the 
result o f the interaction between the two components of the immune system: innate (non­
specific) immunity and adaptive (specific) immunity. In order for the immune system to 
destroy invading pathogens, it must be able to distinguish “se lf’ from “non-self’, thereby 
destroying the pathogen without damaging the host itself. This concept is fundamental to the 
normal functioning of the immune system.
1.1.1 Innate Immunity
The innate immune system consists o f defences which are already in place and do not require 
memory in order to prevent spread and replication of many common infectious agents. The 
first line o f defense is the tough barrier of the skin, which, if  intact, is impenetrable to most 
infectious microbes. Lysozyme (present in most secretions), stomach acids or entrapment in 
the sticky mucous of the nose or throat, with subsequent expulsion by sneezing or coughing, 
are additional non-specific defence mechanisms responsible for repelling most infectious 
agents. Spermine and zinc in semen, lactoperoxidase in milk and commensal organisms in the 
gut and vagina also form part of innate immune defences. If infectious organisms manage to 
penetrate the outer defences of the body, the cells o f the innate immune system are the next 
line o f defence. These include phagocytes (neutrophils, monocytes and macrophages) and 
natural killer (NK) cells. Macrophages and neutrophils have surface receptors (pattern 
recognition receptors) that have evolved to recognize and bind common components 
(elements) o f many bacterial surfaces. Binding of bacterial molecules to these receptors 
triggers these cells to engulf (phagocytose) the bacterium with subsequent killing by oxygen- 
dependent and oxygen-independent microbicidal mechanisms. Phagocytosis induces the 
secretion o f chemical mediators called cytokines, which produce a range o f effects known 
collectively as the inflammatory response. Important components o f the innate immune
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2system include cytokines, collectins (bind to bacterial cells via carbohydrates), NK cells 
(cytotoxic lymphocytes), acute phase proteins (bind and neutralize toxins and limit tissue 
damage) and complement (a multi-component enzyme cascade that enhances phagocytosis by 
coating microorganisms).
Persistent microorganisms, not destroyed by components o f the innate immune system, 
activate the adaptive or specific immune system. Innate immunity mechanisms are vitally 
important, not only to hold the infectious agent in check while the adaptive immune response 
is being activated, but also to direct the immune response that subsequently develops.
1.1.2 Adaptive Immunity
The cells that play a major role in the adaptive immune response are T lymphocytes 
(responsible for cell mediated immunity and also important in humoral immunity) and B 
lymphocytes (responsible for humoral immunity). Each of these lymphocytes carries cell 
surface receptors of a single specificity. When the lymphocyte encounters and binds to a 
specific antigen (in conjunction with a co-stimulatory signal), it proliferates and gives rise to 
many identical progeny, called clones. This process, known as clonal selection, is probably 
the single most important principle of adaptive immunity (Janeway, 1992). Another very 
important property of adaptive immunity is immunological memory: the ability o f the 
immune system to respond faster and more specifically when encountering a pathogen on a 
repeat occasion.
1.1.2.1 B Lymphocytes
B lymphocytes, like T lymphocytes, arise from a common progenitor stem cell in the bone 
marrow. The B cells remain in the bone marrow until they are mature and subsequently 
migrate through the blood stream into peripheral lymphoid organs. Each mature B cell has 
specific cell-surface immunoglobulin (Ig) molecules that are specific for a specific antigen. 
When these antigens come into contact with their specific immunoglobulin receptors (in 
conjunction with a signal provided by T-cells), they are activated and secrete 
immunoglobulins as soluble antibodies. Various isotypes o f immunoglobulin can be secreted 
(IgM, IgD, IgG, IgE, IgA), each with different functions, resulting in a variety of responses to 
the same antigen under different conditions. These antibodies subsequently bind to the 
pathogen, resulting in engulfment and destruction by phagocytes. B-cells are thus extremely 
important in providing defences against extracellular pathogens.
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31.1.2.2 T Lymphocytes
After production in the bone marrow, T lymphocytes migrate to the thymus where they 
mature. These antigen naive T cells subsequently circulate through the blood stream and 
lymphoid organs. Most T cells in peripheral blood express a T cell receptor (TCR) that 
consists o f a heterodimeric c*p chain. Similar to the B cell receptor, each TCR is also a 
specific receptor for a specific antigen. A complex of three cell-surface proteins, collectively 
called CD 3 is associated with the TCR receptor. In addition, T-cells co-express the cell- 
surface proteins CD 4 or CD8, which together with CD 3, are very important in signal 
transduction.
Cells that are infected with pathogens process foreign proteins (from these pathogens) into 
peptide fragments that are transported to the cell surface, stably bound to specialized 
glycoproteins called major histocompatability complex (MHC) proteins. These MHC proteins 
present antigens to T cells. There are two classes of MHC proteins: MHC class I (present on 
all nucleated cells and recognized by CD 8 positive T cells), and MHC class II (present on B 
cells, macrophages and dendritic cells and recognized by CD 4 positive T cells). When the 
specific TCR of antigen-naive cells recognizes specific MHC-bound antigen (in conjunction 
with a co-stimulatory signal), the cells are activated through the TCR with subsequent 
proliferation and differentiation into armed effector cells. On subsequent encounters with 
their specific antigen, these armed effector cells perform a number of functions, the most 
important being killing of infected cells (by CD8 cytotoxic T cells) and activation of 
microbicidal properties of macrophages (by a subset of CD4 positive T cells). Together, these 
make up the most important components of cell mediated immunity.
A small number of T cells express a different T cell receptor. This receptor is called a 
y8 receptor and is expressed on 1-5% of T cells present in peripheral blood and lymphoid 
organs. Generally, y8 T cells are thought to be non-MHC-restricted and function largely as 
cytotoxic T cells.
1.1.2.3 Cytokines
Cytokines are low molecular weight soluble proteins involved in cell growth and 
differentiation, inflammation, immunity and repair. Cytokines play a pivotal role in 
facilitating communication between immune cells and coordinating both the activation and
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4dampening of the immune response to infection or injury. Cytokines are secreted upon 
stimulation (for example, in infection), and, once released, their half-life is short. Cytokines 
normally act in the local mileu in a paracrine or autocrine manner, unlike hormones that are 
transported through the blood stream to their target organs (Hamblin, 1993). Following 
stimulation, many cells (for example: T cells, B cells, macrophages and NK cells), can 
secrete a variety of cytokines, which exert an array of functions. Table 1.1 shows a few well- 
defined cytokines with some known functions.
Table 1.1 Cytokines: sources and functions
Cytokine
Name
MW
(kDa)
Cellular Source Major Functions
IL-2 15-20 T cells t  growth and differentiation o f T cells, B 
cells and NK cells
IL-4 15-19 T cells, mast cells and 
basophils
T differentiation o f B cells and Th2 cells; 
T IgG4 and IgE synthesis; i  
proinflammatory Thl cell and M 0  
function
IL-5 45;
homo­
dimer
T cells, mast cells and 
eosinophils
T growth and differentiation of 
eosinophils and B cells (IgA synthesis)
IL-10 35-40 T cells, B cells and M 0 I  Thl, NK cells and M 0  function 
including cytokine synthesis; T B cell and 
mast cell proliferation
IL-12 35,40
subunits;
heterodi­
mer
B cells and M 0 t  NK cells, CTL and Thl generation, t  
IFN-y production by NK cells and T cells; 
T NK and ADCC activity; costimulates T 
cell proliferation
TGF-p 25;
homo­
dimer
Many cell types 
including T cells and 
monocytes/M0
T IgA production and activation of naive 
T cells; -I activation o f monocytes and 
memory T cells; active in fibroblast 
growth and wound healing
IFN-y 40-70 T cells and NK cells Antiviral; t  M 0  and NK cell function; T 
MHC class I and II surface Ag expression
TNFa 17;
homo­
dimer
Many cell types 
including monocytes 
/M 0 , B cells, T cells
Expressed as cell surface homotrimer, 
also shed in soluble form; T fever and 
septic shock; cytotoxic for many tumour 
cell types
(From: Cytokine/Chemokine Manual. Application Manual. 2" Ed. April 1998. Pharmingen
Bectin/Dickinson Company)
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5Abbreviations:
- increases 
I  - decreases
Thl - type 1 helper cell 
Th2 - type 2 helper cell
M 0  - macrophage 
NK - natural killer
MHC - major histocompatability complex 
BMC - bone marrow cell
Cytokines are usually grouped into 2 classes, depending on their function. T helper cell type 
1 (T hl) cytokines activate macrophages, cytotoxic T cells and NK cells and play a vital role 
in the generation of cell mediated responses to intracellular organisms such as mycobacteria, 
viruses and protozoa. T helper cell type 2 (Th2) cytokines mediate the stimulation and 
differentiation o f B cells, eosinophils and mast cells, all of which are involved in the 
generation of the humoral response, which is important for defense against large extracellular 
parasites such as helminthes.
* IL-10 is usually classed as a Th2 cytokine in the mouse, but both Thl and Th2 phenotypes 
can secrete IL-10 in humans.
The Th phenotypes, which were first described in the mouse model, are characterized by the 
cytokines they produce. Mouse Thl cells were reported to secrete IFN-y, while Th2 cells 
secreted IL-4 (Mosmann et al., 1986). Subsequent studies have also identified Thl and Th2 
cells in humans. These studies have established that Thl cells produce IFN-y, TNF-J3, IL-2, 
while Th2 cells secrete IL-4, IL-5, IL-6, IL-13 (Romagnani et al., 1997; Delespesse et al., 
1997). IL-10 is usually classed as a Th2 cytokine in the mouse, but both Thl and Th2 
phenotypes can secrete IL-10 in humans (Abbas et al., 1996; Zhai et al., 1999). Thl and Th2 
cells negatively cross-regulate each other. IFN-y inhibits the development and response of 
Th2 cells, while IL-4 and IL-10 have strong anti-inflammatory effects and inhibit the 
development and response of Thl cells (Abbas et al., 1996). Other Th cell types include ThO 
cells, (precursors o f Thl and Th2), producing a mixed array of cytokines (Romagnani et al.,
1.1.2.4 Thl and Th2 Cytokines
Th Phenotype Cytokines Produced 
IFN-y, TNF-p, IL-2 
IL-4, IL-5, IL-6, IL-13
Thl
Th2*
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61997), and Th3 cells, (CD 4 positive immune regulatory T cells) that secrete TGF-P (Weiner 
etal., 1997).
1.2.2.5 Measurement of cellular immune responses
Assessment of cells involved in immune responses can be of a quantitative as well as a 
qualitative nature. The quantitation of the various cells and subpopulations of cells, for 
example, T cells and B cells, is usually done by automated cell counting procedures and flow 
cytometrical analysis respectively.
Assessment of the qualitative function of cellular immune responses, specifically in-vitro T 
cell responses, can be done by measuring the ability of these cells to proliferate and produce 
cytokines in response to a variety of stimulants. For in-vitro analysis of proliferative and 
cytokine responses by human cells, most investigators have traditionally used isolated 
peripheral blood mononuclear cells (PBMC) suspended in RPMI supplemented with fetal calf 
serum (FCS) (Hirsch et al., 1999a) or human AB serum (Battacharryya et al., 1999).
More recently, the use of diluted whole blood has been implemented to analyse these 
responses, (Weir et al., 1994; Elliot et al., 1999; van Crevel et al., 1999). Results appear to 
parallel those obtained using PBMC, provided cell counts are within the normal ranges (Weir 
et al., 1994; De Groote et al., 1992). Whole blood assays have a number o f advantages over 
PBMC cultures, these include: 1) a small volume of blood is required, 2) the whole blood 
assay is rapid and simple, 3) no unphysiological cell separation is involved and 4) there is no 
requirement for FCS which is known to contain TGF-P and growth factors produced by 
platelets that could alter T cell cytokine responses in vitro (Daynes et al., 1992). Furthermore, 
investigators have demonstrated that erythrocytes and neutrophils, which are not present in 
PBMC cultures, can provide supplementary cytokines and factors that contribute to 
lymphocyte and monocyte responses (Kalechman et al., 1993; Van der Pouw Kraan et al., 
1995).
The whole blood assay thus appears to be a useful model to quantify cellular immune 
responses and since it was not established in our laboratories, one of the aims o f this project 
was to set up the assay and establish optimal conditions.
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71.2 IMMUNOBIOLOGY OF TUBERCULOSIS (TB)
1.2.1 Introduction
Tuberculosis (TB) infection in humans and mammals continues to be a major cause of 
morbidity and mortality throughout the world. The disease in man is usually caused by 
infection by the obligate human pathogen, Mycobacterium tuberculosis (M.tuberculosis). TB 
is one o f the most important infections in man and is responsible for causing approximately 2 
million deaths and 8 million new cases each year (World Health Organization, 1999).
In recent years, the global TB epidemic has worsened. At least four factors have contributed 
to the re-emergence of TB in industrialized nations such as the United States. These include: 
(1) increased homelessness and substance abuse in inner cities; (2) the growing epidemic of 
the acquired immunodeficiency syndrome (AIDS); (3) the migration of infected individuals 
from high-prevalence countries and (4) the decline of tuberculosis control programs. In 
addition, the situation is worsened by the increasing incidence o f multi-drug resistant (MDR) 
TB.
The largest burden o f TB is found in Southeast Asia (3 million cases per year) (World Health 
Organization, 2000). Sub-Saharan Africa has 1.6 million cases per year and the overall 
notification rate for South Africa specifically was reported to be 366 new cases/100 000 
population (Beyers et a l., 1996). The highest notification rate within South Africa was 
reported in the Western Cape (718 new cases/100 000 population) (Beyers et a l., 1996).
1.2.2 The bacillus
Robert Koch first identified the tubercle bacillus more than a century ago. It is a small, non- 
motile rod, measuring between 1 and 4 |im in length and 0.3 to 0.6 jim in diameter. Three 
aspects o f mycobacterial physiology strongly influence the pathogenesis of TB disease. First, 
the tubercle bacillus is an obligate aerobe, which is probably partly responsible for the tissue 
tropism, growing well in oxygen-rich tissues such as lungs and more slowly in oxygen-poor 
tissues, such as the liver (Corper et al., 1927). Second, in optimal conditions, the bacillus 
grows very slowly, with a doubling time of about 20-24 hours. This contributes to the slowly 
progressing, chronic nature o f the disease. Third, the bacillus has an extremely complex and 
lipid-rich cell wall. This lipid-rich wall is responsible for many o f the unusual characteristics
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8of the mycobacterium, for example, chemical and stress resistance, ability to resist the killing 
mechanisms o f macrophages and to replicate intracellularly, anti-microbial resistance and 
ability to stimulate a potent adjuvant response. This last characteristic may contribute to 
immunopathological manifestations of TB disease.
1.2.3 Susceptibility to TB
The host immune response, as well as the innate virulence of the TB bacillus itself, plays a 
major role in determining the clinical manifestation and final outcome of the infection. There 
is marked heterogeneity in the immune response of different individuals to M. tuberculosis. 
Resistance and control of the initial infection appears to occur in about 95% of normal hosts, 
while the other 5% develop progressive primary TB (Ellner, 1997). These heterogeneous 
immune responses to M. tuberculosis are determined by genetic, socio-economic as well as 
environmental factors. The innate immune system appears to play a pivotal role in 
susceptibility versus resistance to infection with M. tuberculosis, while the adaptive immune 
response appears to be involved in the control o f the outcome of infection. In mice, IFN-y is 
crucial for control of M.tuberculosis infection (Cooper et al., 1993; Flynn et al., 1993), as are 
IL-12 (Cooper et al., 1997), and CD 4 positive cells (Scanga et al., 2000). Polymorphic 
determinants o f susceptibility to mycobacterial infection in mice have been identified as 
nramp 1 and the sstl locus (Kramnik et al., 2000). Individuals who have been identified with 
single defects in the IFN-y receptor and IL-12 receptor genes show an increased susceptibility 
to mycobacterial infections (Newport et al., 1996). In most individuals, however, multiple 
genetic factors have subtle effects on the immune response. These susceptibility genes or loci 
include the vitamin D receptor gene and others located on chromosomes 3, 5, 6, 8, 9, 15 and 
X (Hill et al., 1998).
Socio-economic factors also have an impact on susceptibility to M.tuberculosis. Since the 
beginning o f the 19th century, there has been a sharp decline in the incidence of TB disease in 
industrialized countries. This steady decline coincided with an increase in the standard of 
living and has been interrupted by temporary increases during the two world wars.
Age is also an important risk factor for the development o f TB disease. Young children who 
are exposed to M.tuberculosis are at increased risk of developing TB disease, especially 
disseminated and meningeal disease, compared to adults. This is more commonly seen in 
children younger than 1 year of age (discussed in more detail in section 1.3.3).
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91.2.4 The diagnosis of tuberculosis
The diagnosis of TB is a vitally important element in the control of the disease. Not only 
should it be fast, but it should be accurate as well. The gold standard remains clinical 
examination, combined with the microscopic examination o f sputum and culture o f bacteria. 
M.tuberculosis culture can take up to 8 weeks and is not always successful, as the bacillus 
cannot be cultured in 10-20% of cases (Pottumarthy et al., 1999). Patients with subclinical 
infection present a further problem as current diagnostic strategy depends on patients 
presenting with clinical symptoms. Therefore the rapid and accurate diagnosis of 
M.tuberculosis infection can be problematical in many cases. There is thus an urgent need for 
better and faster diagnostic tests in TB. Assessment of human in-vitro cellular immune 
responses to TB infection could help in the development o f such tests, as well as identify 
possible correlates of protection.
Various types of blood tests have been suggested as an alternative method of diagnosing TB. 
Antibody responses have not been helpful in this respect as they are directed at a broad set of 
antigens. In addition, responses vary among patients and the serological assays are not 
sensitive enough. As M.tuberculosis is an intracellular pathogen, an alternative approach is 
the assessment o f whether a patient’s T cells have been sensitised to M.tuberculosis antigens. 
This is the principal on which the tuberculin skin test (TST) or Mantoux skin test is based. 
Tuberculin or purified protein derivative (PPD) has generally been used as the M.tuberculosis 
antigen in this test, but the greatest disadvantage of PPD is that most of the protein 
components are shared between mycobacterial species or with unrelated species of bacteria 
(Anderson et al., 1994). This results in a decreased specificity of the TST. Many researchers 
have attempted to identify and isolate specific antigens from M.tuberculosis for use as 
diagnostic reagents (Nagai et al., 1991). This will be hopefully be achieved by the 
identification of regions in the M.tuberculosis genome that are absent in BCG and most non- 
tuberculous mycobacetria (Behr et al., 1999).
PPD has also been used for in-vitro detection of specific IFN-y-producing lymphocytes that 
have been sensitised to mycobacterial antigens.
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1.2.5 Initial TB infection
The route o f entry of the mycobacterium into the host is usually via inhalation o f aerosolised 
bacilli into the respiratory tract. Only particles smaller than 5-lOp.m in diameter, containing 
1-10 bacilli, are small enough to reach the alveoli (Sonkin, 1951). Less than 10% of 
aerosolised bacilli will reach the alveoli, while the majority (droplets of a larger size) are 
expelled from the lower respiratory tract by the physical barriers of the nasopharynx and 
upper respiratory tract (reviewed by Fenton and Vermeulen, 1996).
After inhalation into the alveoli, the M.tuberculosis organism may either be killed, multiply 
(causing primary TB) or become dormant (causing latent infection). These so-called dormant 
bacteria may reactivate later, causing postprimary TB.
1.2.6 Interaction o f M.tuberculosis with monocytes and macrophages
The M.tuberculosis bacterium binds to alveolar macrophages via many receptors. These 
include Fc receptors, complement receptors, mannose receptors, CD 14 and scavenger 
receptors (reviewed by Schluger and Rom, 1998). The choice of receptor used can also 
influence the cellular response. For example, entry o f IgG-opsonised mycobacteria via Fc 
receptors promotes production of reactive oxygen intermediates and allows phagosome- 
lysosome fusion (Armstrong et al., 1975) while internalisation via CR3 inhibits the activation 
of the respiratory burst (Le Cabec et al., 2000).
Once the organism gains entry into the cell, it is internalized into a phagosome where it can 
potentially be killed by a number of mechanisms, many o f which are poorly understood. In 
mice, reactive nitrogen intermediates (RNI), particularly nitric oxide (NO), are a prerequisite 
for the destruction of the organism. It has been reported that inducible nitric oxide synthase- 
(iNOS)-knock out mice demonstrate more rapid M.tuberculosis replication than wild type 
mice (MacMicking, 1997). In humans, macrophages can also produce NO, although at lower 
levels than that of mice and RNI probably play a role in the killing of the organism in human 
macrophages (reviewed by Schluger and Rom, 1998 and Fenton and Vermeulen, 1996). 
Reactive oxygen intermediates (ROI) alone have been shown to be insufficient to kill the 
M.tuberculosis organism, but they enhance killing by RNI (reviewed by Fenton and 
Vermeulen, 1996). Apoptosis of infected macrophages, induced by hydrogen peroxide, 
purinergic receptors (Lammas et al., 1997) or cytotoxic T cells, is another mechanism that the
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host can potentially use to kill the organism. Apoptosis (by CD 8 T cells), mediated by the 
secretion o f granules, but not via the fas pathway, contributes directly to mycobacterial 
killing (Stenger et al., 1997). Finally, cytotoxic T cells can also secrete small proteins called 
TIA-1 that have been shown to be involved in apoptosis (Law et al., 1996).
The M.tuberculosis bacillus utilizes a number o f strategies to avoid being killed within the 
macrophage. It appears to modify the maturation of the phagosomal compartment via 
alterations in the protein content, including altered Rab GTPase composition (Clemens et al., 
2000) and exclusion of the vacuolar ATPase with consequent lack of acidification (Sturgill- 
Koszycki et al., 1994). In addition, mycobacterial products such as sulphatides and 
lipoarabinomannan (LAM) have the ability to scavenge free radicals or inhibit the respiratory 
burst (reviewed by Fenton and Vermeulen, 1996). Finally, M.tuberculosis induces the 
secretion o f immunosuppressive cytokines such as TGF-P and IL-10 which results in the 
down regulation of many responses that are necessary for the elimination of the 
M.tuberculosis organism (discussed in more detail in 1.2.8).
Mycobacteria also deploy a number of strategies to acquire essential nutrients. One of these 
nutrients is iron, which is required for intracellular survival. Macrophages also require iron as 
a co-factor in the induction of microbicidal effector mechanisms and this iron is acquired 
from the transferrin receptor, which internalizes extracellular iron bound to transferrin and 
lactoferrin. This complex is transported to an early endosomal recycling compartment where 
the mildly acidic conditions assist in the release o f iron from the receptor. M.tuberculosis 
competes for this iron in a number o f ways. For example, the mycobacterial phagosome is 
restricted in its maturation state to that of an early endosome. This endosome resides in the 
recycling endosomal pathway, which results in free access to the transferrin receptor with its 
iron bound to transferrin (Russel et al., 1996). In addition, mycobacteria have also developed 
specialized iron-binding molecules called siderophores. These molecules have a high affinity 
for intracellular iron and transfer iron from host proteins to specific mycobactin molecules in 
the mycobacterial cell wall (Gobin et al., 1996).
1.2.7 Regulation of immune responses by T cells
Before the development o f a specific immune response, macrophages infected with 
M.tuberculosis are stimulated to produce IL-12, which subsequently induces NK cells to
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secrete IFN-y. This cytokine, together with TNF-a (also produced by infected macrophages), 
stimulates the production of more IL-12 from the infected macrophages, creating a positive 
feedback loop.
Macrophages infected with M.tuberculosis, also present processed antigens via MHC class II 
to CD 4 positive T cells, while some antigens, which escape to the cytosol o f the 
macrophage, can be presented via MHC class I to CD 8 positive cells. Lipid antigens from 
mycobacterial cell walls (mycolic acid and LAM) are also recognized by T cells when 
associated with the non-polymorphic CD lb  molecules found on APCs. On recognition of the 
antigen, naive T cells are stimulated to produce a mixture of cytokines (Th 0 response). After 
prolonged stimulation, CD 4 cells tend to polarize to either type 1 cells secreting mainly IFN- 
y and IL-2, or type 2 cells secreting mainly IL-4, IL-5, IL-6 IL-10 and IL-13. A number of 
factors can influence the polarization of type 1 and type 2 cells. Infected macrophages also 
produce the immunosuppressive cytokines TGF-P and IL-10, which are capable o f down- 
regulating type 1 responses.
CD 4 positive T cells play a crucial role in amplification of the host immune response by the 
activation o f effector cells and recruitment of additional cells to the site of disease. The 
importance o f this subset o f T cells was confirmed in a number o f experimental models using 
antibody depletion or knock-out mouse strains deficient in CD 4 positive T cells (Scanga et 
al., 2000). Also, the increased susceptibility of HIV-infected patients to TB, further 
demonstrates the critical role of CD 4 positive T cells. The main function of these cells is 
proposed to be the production of cytokines, specifically IFN-y, which plays a crucial role in 
macrophage activation with subsequent induction of microbicidal effector mechanisms. In 
order to be activated, CD 4 cells require the help of certain co-stimulatory molecules that are 
present on APCs. Although little is known about the status o f these co-stimulatory molecules 
in TB, one such molecule, CTLA-4, has been reported to be down-regulated in TB patients 
(Gong et al., 1996).
CD 8 positive T cells appear to be involved in the direct lysis and induction of apoptosis of 
infected cells. The importance of their role in cellular immunity was demonstrated in P2- 
microglobulin-knockout mice that were unable to express MHC class I molecules and were 
highly susceptible to mycobacterial infection (Flynn et al., 1993). In addition, mice deficient
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in the transporter associated with antigen processing (TAP) (Behar et al., 1999), CD 8a  and 
perforin (Cooper et al., 1997) were all more susceptible to M.tuberculosis infection than wild- 
type mice. Finally, CD 8 positive cells are capable o f secreting cytokines such as IFN-y and 
IL-4 and thus may play a role in regulating the balance o f type 1 and type 2 cells.
The role o f y5 T cells in host immune response has not been well clarified, but there has been 
some evidence that these cells do play a role. They appear to accumulate early, both in the 
lesions o f leprosy patients (Modlin et al., 1989) and in experimental M.tuberculosis infection 
of mice (Griffen et al., 1991), In addition, mycobacterial phospholigands stimulate all Vy252- 
bearing cells. The manner in which this activation occurs is not fully understood, but it results 
in a high frequency of mycobacteria-specific y8 cells, which appears to be o f the same 
magnitude as the clonal expansion o f a p  T cells (Kaufmann, 1996).
1.2.8 Regulation of immune responses by cytokines
The presence o f cytokines, secreted by T cells, macrophages and NK cells, ultimately leads to 
the recruitment and activation of monocytes and macrophages that demonstrate enhanced 
microbicidal activity. The profile produced (type 1 versus type 2) could play an important 
role in the outcome of infection (protection versus disease). This is demonstrated in a related 
mycobacterial disease, leprosy, in which the T cells o f patients with progressive lepromatous 
disease secrete little IFN-y and IL-2 (type 1 cytokines) and increased amounts o f IL-4 (type 2 
cytokines), when compared to patients with tuberculous leprosy, the more benign form of 
disease. (Bloom et al., 1992). Other diseases with clinical manifestations that may be related 
to the cytokine profile present at the site of disease are asthma (Kay, 1996), Crohns disease 
(Parronchi et al., 1997) and organ transplantation (Piccotti et al., 1997).
IFN-y appears to play a vital role in the control of mycobacterial infection. Lymphocytes 
present at the sites o f mycobacterial infection produce IFN-y, especially at those sites where 
effective T cell-mediated immunity is observed (i.e. pleuritis) (Barnes et al., 1993). Mice 
deficient in IFN-y itself, or IL-12, a critical IFN-y-inducing cytokine, were highly susceptible 
to M.tuberculosis challenge (Cooper et al., 1993; Cooper et al., 1997). In addition, patients 
from families with mutations in the a  chain o f the IFN-y receptor are highly susceptible to 
infections with atypical mycobacteria. (Newport et al., 1996; Jouanguy et al., 1996). Other 
patients, also with severe atypical mycobacterial infections, appear to have defective IL-12 or
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IFN-y production (Frucht et al., 1996). In mice, IFN-y may fully activate macrophages to kill 
M.tuberculosis in vitro by NOS induction. In humans, however, IFN-y alone does not fully 
activate macrophages to kill or inhibit growth of M.tuberculosis. It may act together with 
TNF-a and 1,25-dihydroxyvitamin D3 to induce killing or growth inhibition of 
M.tuberculosis by macrophages (Denis et al., 1991).
IL-2 promotes an increase in macrophage-activating factors by inducing proliferation of 
antigen-reactive T cells. Treatment with recombinant IL-2 in mice infected with M.bovis 
reduces bacillary load and improves clinical status (Jeevan et al., 1988). Similar findings 
were seen in humans with lepromatous leprosy and MDR TB (Kaplan et al., 1991; Johnson et 
al., 1995).
Activated macrophages and T cells produce large amounts o f TNF-a. In M.bovis BCG- 
infected mice, treatment with anti-TNF antibodies resulted in lack of granuloma formation 
and failure to contain infection. TNF-a or 55 kd TNF receptor knock-out mice showed 
similar findings (Kindler et al., 1990). In humans, alveolar macrophage-derived TNF- 
a  appears to inhibit the in-vitro growth of M.tuberculosis more than alveolar monocyte- 
derived TNF-a (Hirsh et al., 1994a). Excessive amounts of TNF-a contribute to 
immunopathology such as fever, cachexia and tissue damage. The TNF inhibitor, 
thalidomide, appears to be able to reverse some of the tissue necrosis in mice (Moreira et al., 
1997).
IL-12 is an important promoter of type 1 responses and increased levels have been found in 
pleural fluids and lymph nodes o f TB patients (Zhang et al., 1994). Mutations in the IL-12(31 
receptor gene or IL-12p40 genes, resulting in absence o f functional IL-12 receptor 
complexes, have been shown to result in poor granuloma formation in patients with 
disseminated atypical mycobacterial disease (Altare et al., 1998; de Jong et al., 1998).
Human and murine macrophages and human T cells secrete IL-10 in-vitro in response to 
M.tuberculosis infection. IL-10 also suppresses T cell function and de-activates macrophages 
(Othieno et al., 1999). In addition, it down-regulates the effects of inflammatory cytokines 
such as IFN-y and TNF-a and thereby limits the extent of tissue damage. PBMCs from TB 
patients have been shown to produce higher levels o f IL-10 than controls (Torres et al., 1998)
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and patients with active TB also demonstrate elevated serum levels of this cytokine (Verbon 
et al., 1999). In a study of tuberculous pleural fluids (Barnes et al., 1993), the presence of IL- 
10 was shown at the site of pathology. In contrast, no IL-10 was demonstrated in BAL fluids 
from patients with intrapulmonary TB (Schwander et al., 1998). IL-10 has recently been 
shown to act together with TGF-P to suppress PPD-induced IFN-y production in PBMCs 
(Othieno et al., 1999). In addition, IL-10 production by monocytes was shown to be 
moderately up-regulated by the presence of TGF-P (Othieno et al., 1999).
TGF-p is secreted by macrophages and monocytes in response to infection by M.tuberculosis 
and is regarded as a macrophage inactivator. Most o f its effects are anti-inflammatory and 
these include: interference with NK and CD 8 T cell function, inhibition o f T cell 
proliferation and interference of macrophage production of reactive oxygen and nitrogen- 
intermediates. The presence o f TGF-P enhances the growth of M.tuberculosis in human 
macrophages and induction o f this cytokine may be a strategy by which the bacillus 
manipulates the host immune response to its own advantage (Hirsh et al., 1994b). However, 
TGF-P production may benefit the host by limiting the extent of tissue damage as well as 
containing the infection by inducing fibrosis and angioneogenesis. TGF-P, induced by 
M.tuberculosis, both directly and indirectly (through IL-10 induction) may be responsible for 
the down-regulation o f T cell function and macrophage de-activation (Othieno et al 1999).
IL-4 production by lymphocytes from susceptible mice was increased compared to resistant 
mice and mice with disrupted IL 4 genes showed normal resistance to infection with 
M.tuberculosis (North et al., 1998). In humans, the measurement of IL-4, an important type 2 
cytokine, has not been well documented. This is probably due to technical problems (very 
low levels) involved in the accurate assessment of IL-4 concentration in samples. However, 
increased levels o f IL-5, another type 2 cytokine, have been found in a cohort of individuals 
in Uganda, a TB endemic area (Elliot et al., 1999). The authors speculate that this cytokine, 
which may relate to a high prevalence of helminth infestation, may suppress type 1 cytokines 
and thereby have a possible deleterious effect on protective immunity against mycobacterial 
pathogens.
Taken together, susceptibility to M.tuberculosis may be due to number o f defects including 
abnormal IFN-y receptors, defects in signal transduction, inefficient killing or antigen
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presentation, deficient expression o f co-stimulatory molecules or of protective cytokines 
(such as IL-12), or excessive secretion of suppressive cytokines such as TGFP and IL-10. 
Reduced killing by cytotoxic T cells, abnormal T cell function (as demonstrated by increased 
susceptibility to M.tuberculosis infection by HIV-infected people) or insufficient or 
inappropriate cytokine secretion may all play a role in susceptibility to M.tuberculosis.
In order to investigate this last possibility, many researchers have compared cytokine 
production in patients with active pulmonary TB to that of healthy sensitised individuals. A 
number o f studies have documented differences in cytokine production between TB patients 
and healthy controls. The most well-documented difference is seen in IFN-y production, 
which has repeatedly been shown to be decreased in PPD-stimulated PBMC from TB patients 
as opposed to healthy controls (Turner et al., 2000, Torres et al., 1994, Hirsch et al 1999b). 
Although the majority of studies confirm the diminished production of this cytokine in the 
periphery, there have been a few reports where this was not the case (Surcel et al., 1994). 
When IFN-y production was measured at the site of disease, it was found to be abundant, 
suggesting compartmentalization o f cytokines (Schwander et al., 1998; Barnes et al., 1993). 
IL-2 production has also been shown to be depressed in patients with active pulmonary TB 
(Hirsch et al., 1996; Barnes et al., 1992). Type 1 responses therefore appear to be depressed 
in TB patients as opposed to healthy controls. A number o f reports have demonstrated 
increased levels o f TGF-P and IL-10 from PPD-stimulated PBMC of patients with active 
disease as compared with healthy sensitised individuals (Hirsh et al., 1999; Toozi et al., 
1995). TGF-P and IL-10 are known to down-regulate type 1 responses therefore providing a 
possible explanation for depressed type 1 responses in TB patients.
Although a variety o f cytokines, chemokines and other soluble factors have been investigated 
in M.tuberculosis, information concerning the role that they play is still limited and often 
controversial. Many conflicting results have been found in different studies. For example, 
high levels (Hirsch et al., 1999b) and normal levels (Hirsch et al., 1996) of IL-10 were found 
in M.tuberculosis -stimulated PBMC from TB patients. Some studies have also shown a 
heterogeneous pattern of type 1 and type 2 cytokines when stimulated with M.tuberculosis 
antigens (Barnes et al., 1993; Orme et al 1993). These conflicting results have also been 
reported in different patient populations (Hirsh et al., 1996). While different culture 
conditions may be responsible for some of the differences, variations in the intrinsic immune
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response o f patient populations may also be important. For example, malnutrition (unrelated 
to TB) can drastically alter the production of cytokines (Dai et al., 1998). Secondly, TB 
patients, with asymptomatic parasite infection can have up-regulated production o f type 2 
cytokines which in turn could down-regulate type 1 cytokine responses (Bentwich et al.,
1999). Thirdly, the severity of TB disease could affect the cytokine response (Seah et al.,
2000) and lastly, cytokine responses are altered during and after TB therapy (Hirsch et al., 
1999b).
1.2.9 Immune responses after tuberculosis therapy
Many reports of immune responses of adult TB patients at the time of diagnosis have been 
published. On the other hand, very few studies have re-examined the immune responses of 
these patients after TB therapy. Hirsch et al., (1999b) followed patients and healthy sensitised 
controls eighteen months after TB diagnosis and re-assessed PBMC cytokine production after 
PPD stimulation. IFN-y levels were still depressed even though the immunosuppressive 
cytokines, TGF-p and IL-10, had returned to baseline levels. The authors speculate that this 
persistent IFN-y depression may relate to reactivation of latent TB. Verbon et al., (1999) 
measured serum cytokines in TB and healthy sensitised controls at the time o f TB diagnosis 
and again after TB therapy was completed. He showed that, compared to controls, IFN-y and 
IL-10 levels were increased in TB patients, at the time o f diagnosis and decreased after TB 
treatment. The increased IFN-y level in patients was not related to increased IL-12 levels, as 
this was similar to those found in controls.
The status o f the immune response in TB patients after treatment is largely unknown. 
Therefore, a further aim of this study was to quantify immune responses of TB patients after 
therapy, and compare it to data found before TB therapy.
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1.3 MATURATION OF THE IMMUNE SYSTEM, AGE AND TB
1.3.1 Introduction
A number of components of the immune system that seem to be important in host defence are 
different in adults and infants. These differences, both qualitative and quantitative, probably 
contribute in part to the greater risk o f disease in children o f particular ages.
The development o f the immune system in the human begins during the first month of 
gestation with haemopoeitic stem cells in the yolk sac (Huston et al., 1997). Up to three 
months, haematopoeisis occurs mainly in the liver until the skeletal components are 
developed. Thereafter, the bone marrow becomes the major site o f haematopoeisis. The 
immune system develops throughout life and although the basic requirements for the 
development of immune competence are present at birth, the complete expansion of the 
immune system requires learning or maturation. This is achieved only by encounter with 
pathogens, which induce a response as well as memory for a specific encounter.
1.3.2 Maturation of the immune system
1.3.2.1 Enumeration of Immune cells during maturation
The absolute numbers of leukocytes, total lymphocytes, as well NK cells, declines with age 
(Erkeller-Yuksel et al., 1992; Comans-Bitter et al., 1997), while the percentage of T cells 
within the total lymphocyte population increases with age (Erkeller-Yuksel et al., 1992). 
Studies o f CD 4/CD 8 ratios, however, revealed controversial results. Wiener et al., (1990) 
found no significant changes across age groups, while other researchers reported increased 
CD 4/CD 8 ratios in cord blood (Solinger et al., 1985) or in the first year o f life (Comans- 
Bitter et al., 1997). Peripheral blood monocyte numbers, in neonates, appear to be similar to 
that o f adults (Weinberg et al., 1985).
1.3.2.2 a p  TC R T cells
a) Immature surface phenotype
Neonatal peripheral blood T cells usually contain a high frequency of T cells which double­
stain for CD 4/CD 8, as well CD 1, in contrast to adult peripheral blood T cells, which do not 
(Griffiths-Chu et al., 1984). In addition, more than 75% of CD 4 + cord blood T cells express 
CD 38 (common thymoctye) surface antigen, compared to a small number of adult cells
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(Clement et al., 1990). CD 40 ligand, a receptor involved in T-cell-mediated macrophage 
activation, is generally expressed at lower levels on activated neonatal T cells in contrast to 
adult T cells (Noelle et al., 1996), but levels increase within the first few months of life 
(Durandy et al., 1995).
b) “Memory versus Naive” as detected by surface expression of the common leukocyte 
molecule, CD 45
Differential expression of CD 45 iso-forms is usually used to identify functionally 
heterogeneous CD 4+ T cell subsets. “Naive” precursor -T cells are CD 45 RA+RO’, while 
recall-antigen responsive T cells (memory T cells) are CD 45 RA'RO+ (Hassan et al., 1993). 
CD 45 RA expression occurs in up to 90% of cord blood CD 4 positive T cells, compared to 
approximately 50% in adults (Hannet et al., 1992). CD 45 RA'RO+ is expressed on <5% of 
the peripheral blood T cell pool in the cord and steadily increases throughout childhood 
toward adult levels (30-45%), presumably as a result of repeated antigen exposure (Hannet et 
al., 1992). Adult levels o f CD 45 RA'RO+ expression are generally reached between 15-20 
years o f age and are comparable between CD 4 and CD 8 subsets as well as ap  TCR and y5 
TCR T cell populations (Hayward et al., 1989). Researchers have also identified a unique CD 
45 RA'RO’ subset in cord blood, which may be the immediate precursor of unprimed CD 45 
RA+RO' T cells (Bofill et al., 1994).
c) Cytotoxic effector functions
In the neonate, anti-viral immunity is diminished compared to adults during primary 
infection. Neonatal T cell cytotoxic activity was shown to be reduced after stimulation with 
PHA (reviewed by Holt, 1995).
d) T- cell suppressor activity
Non-specific in-vitro T cell “suppressor” activity in various cell types in experimental 
animals has been shown to be more active during the immediate post-natal period than in 
subsequent adulthood (Strober, 1984). This appears to be the case in humans as well. Adult T 
cell proliferation in-vitro is inhibited by both foetal and neonatal lymphocytes (Olding et al., 
1976) and this immunosuppressive activity has been suggested to play an important role in 
the “maintenance” of normal pregnancy.
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e) Cytokines
Differences in cytokine production between neonates and adults have been observed. The 
underlying causes for these differences are mostly unclear, although a crucial factor is 
probably a lack of exposure to antigen. This is supported by the finding of a predominantly 
“naive “ T cell phenotype in neonatal peripheral blood, (CD 45 RA+RO'), which decreases 
with age (Hassen et al., 1996). However, other factors, such as inefficient antigen 
presentation and/or T cell help may be important in influencing the level of cytokines 
produced.
It is generally accepted that the capacity to produce IFN-y is markedly reduced 
(approximately 10% of adult capacity) in neonatal T cells. (Holt et al., 1995; reviewed by 
Smith, 1997). One contributing factor to this observation is that naive T cells, compared to 
memory T cells, are deficient in the production of this cytokine (Ehlers et al., 1991). Other 
possible reasons have been suggested: neonatal T cells are more sensitive to prostaglandin E2 
(Wakasugi et al., 1985), or inefficient accessory cell activity of neonatal macrophages 
(Taylor and Brysan et al., 1985). It has also been found that variations in the rate of postnatal 
maturation o f T cell competence, as shown by IFN-y and IL-4 production pattern, may be 
associated with the development o f atopy (Elsasser-Beile et al., 1991). The human foetus and 
neonate is unusually susceptible to infection with intracellular pathogens and this 
susceptibility has been proposed to be due to the inability o f neonates to produce sufficient 
IFN-y (Wilson et al., 1986). IFN-y production increases within the first few months of life 
and the majority o f children acquire levels equivalent to adults 2-5 years after birth (Frenkel 
et al., 1987).
Reports on the production o f IL-2 by neonatal T cells are controversial. It has been reported 
to be similar to that o f adults (Miyawaki et al.,1985), higher than in adults (Wilson et al., 
1986), or significantly lower (Lilic et al., 1997). These disparities may be due to the use of 
different stimulating agents (Miyawaki et al., 1985). IL-2 receptor expression in neonates is 
comparable to that found in adults (Wilson et al., 1986).
Neonates and young children (under the age of 10) produce less TNF-a (with non-specific 
mitogenic stimulation), than older individuals (Wilson et al., 1986; Elsasser-Beile et al.,
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1995). However, during active disease episodes, eg, bacterial meningitis (van Furth et al., 
1995), young children are quite capable of producing increased levels o f TNF-a.
Studies on IL-10 production also report contradictory results. Chheda et al., (1996) claimed 
increased production at birth compared to adults, while Seghaye et al., (1998), using a whole 
blood assay, report similar levels of IL-10 in cord blood compared to adult blood, after LPS 
stimulation.
Mitogenic stimulation of IL-4 has been shown to be lower in younger children compared to 
adults (Tang et al., 1995). Possible mechanisms suggested may involve naTve/memory 
subpopulations as well as other inhibitory cellular or serum factors.
Reports on age-related differences between IL-12 or TGF-P production have been not been 
documented.
1.3.2.3y5T cells
y5 T cells account for 1 to 5% of adult human peripheral blood T cells, whereas negligible 
numbers are found in the cord blood o f newborn infants (Smith et al., 1990). These numbers 
increase progressively with age (Pecchold et al., 1994). y8 T cells that recognize isoprenyl 
pyrophosphates of mycobacteria (vy2v82 T cells) are abundant in adults, but infrequent in 
neonates (Tsuyuguchi et al., 1991; Smith et al., 1997).
1.3.2.4 B cells
The number o f CD 19 positive B lymphocytes has been shown to increase from birth until 
five months o f age. This remains stable until about 5 years, after which there is a gradual 
decline to adult age (Comans-Bitter et al., 1997).
1.3.2.5 NK cells
The number and percentages of NK cells has been found to be highest in cord blood 
(Erkeller-Yuksel et al., 1992). Cord blood NK cells are functionally less active than those of 
adults and have reduced IFN-y production (Hannet et al., 1992; Abo et al., 1983). This is 
possibly due to their immature state or due to a delay in the development of other cytokine- 
generating cells, which is necessary for complete NK activation.
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1.3.2.6 Antigen-presenting macrophages and monocytes
Alveolar macrophages (AM) in neonatal animals have been relatively well-studied. They 
appear to be deficient in number as well as function, compared to their adult counterparts. 
The numbers increase during the early postnatal period, while the effector functions increase 
postnatally at varying rates in the different species (Weiss et al., 1986; D’Ambola et al., 
1988). Although there is minimal data on humans, it appears that the human AM population 
also expands during early postnatal life (Alenghat et al., 1984) and demonstrates depressed 
anti-microbial function compared to adults (D’Ambola et al., 1988).
Neonatal and adult monocytes are similar in terms o f absolute numbers and antimicrobial 
activity, but chemotaxis o f neonatal monocytes is reduced in-vitro (Raghunathan et al., 1982). 
Recruitment of monocytes into tissues is also reduced in neonates (Bullock et al., 1969). 
Adult levels o f monocyte chemotaxis are attained at 6-10 years of age (Raghunathan et al., 
1982). These relative monocyte recruitment deficiencies may play a role in the reduced 
ability o f neonates and children < 2 years of age to demonstrate delayed type hypersensitivity 
(DTH) after microbial infection. IL-6 (Yachie et al., 1992) and TNF-a (Burchett et al., 1988) 
production by neonatal monocytes is decreased. This may contribute to defective 
inflammatory activity and may also play a role the decreased febrile response in neonates 
(Klein et al., 1983).
The capacity o f neonatal monocytes and macrophages to mediate IFN-y production by NK 
cells or T cells after lipopolysaccharide (LPS) or mitogen stimulation is reportedly only half 
that o f adult cells (Taylor and Bryson, 1985). In general, the capacity of neonatal monocytes 
and macrophages to secrete, and respond to, a number o f cytokines is similar or modestly 
reduced compared to adults (Rowen et al., 1995).
1.3.2.7 Antigen presentation
MHC class II-restricted presentation of peptide antigens appears to be intact, as monocytes 
from human neonates can present antigen to maternal T cells as efficiently as maternal 
monocytes (Lewis and Wilson, 1995). These studies, however, examined antigen presentation 
to memory maternal T cells and not to neonatal T cells. Human cord blood dendritic cells 
have been shown to be less efficient APCs and stimulators o f allogeneic responses than adult 
dendritic cells (Hunt et al., 1994). Dendritic cells from infants appear to have decreased
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antigen presentation to naive, neonatal T cells which does not reach adult levels until 1 year 
of age (Clerici et al., 1993).
The dendritic cell is a particularly important cell in neonates and infants, as the initial 
response to antigen is most dependent on efficient antigen presentation by these cells. 
Reduced dendritic cell function may therefore cause a delay in the initiation of an appropriate 
antigen-specific response, especially in the draining lymph nodes of the infant respiratory 
tract (Holt, 1995), and may therefore play a role in the development of disease.
1.3.2.8 Age-related risk of infectious diseases
Infancy and early childhood are generally acknowledged to be high-risk periods for infectious 
diseases, for example: gram negative and group B streptococcus infections are common 
during the first month o f life. Thereafter, between 1 and 6 months o f age, viral infections 
often occur. During the next 12 months, the major causative agents of infections are viruses 
and bacteria, particularly inflammatory cocci. Progressive development of immunologic 
memory and function occurs from the age of two years (reviewed by Pabst et al., 1980). The 
same authors hypothesized that a peak resistance period (to a number of infections), occurs 
around 10 years of age. They also demonstrated that overall human mortality followed a 
parabolic curve, with the “nadir” at 12 years of age, the time when total lymphoid tissue mass 
in the human body peaked. After this, overall mortality (due to infectious diseases), rises 
again, with a parallel decline in lymphoid tissue mass and immunoglobulin-producing cells 
(reviewed by Pabst et al., 1990).
It is generally accepted that, under neutral conditions, neonatal T cells are biased towards a 
type 2 profile. This bias could possibly play a role in the increased susceptibility to certain 
infections early in life and could be due to the type 2-cytokine mileu of pregnancy and/or 
altered APC/T cell interactions.
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1.3.3 Age and TB
1.3.3.1 Age-related risk o f TB
It is well known that there is an age-dependent risk for developing active TB, irrespective of 
the prevalence o f infection in a given region. Children younger than the age o f five years are 
highly susceptible to the development of active TB (especially disseminated and meningeal 
disease) and it is estimated that 20-40% of the infected children develop signs and/or 
symptoms o f TB. Between the ages of 5 and 12 years the incidence is at a lifetime low. 
Thereafter, during adolescence, the lifetime risk of developing TB disease is approximately 
15% until early adulthood where it remains at about 10% until late in life (Donald and 
Beyers, 1996).
1.3.3.2 Assessment o f immune responses and diagnosis of TB in children
The diagnosis o f TB disease in children is usually problematical. It is often difficult to obtain 
sputum from children with TB and the number of bacteria is generally low as TB is not 
usually a pulmonary cavitatory disease in children. This leads to a low yield o f cultures. 
There is thus an urgent need for the development of improved diagnostic tests for children. 
Studies comparing cellular immune responses in children with TB to healthy sensitized 
controls o f the same age would provide important information, which could be used for the 
development of such improved diagnostic tests, as well as identify possible correlates of 
protection to TB. Unfortunately, very few studies involving children and the cellular immune 
responses to TB have been published. Diele et al., (2000) assessed lymphocyte proliferation 
after stimulation of PBMC with PPD and found no difference between patients and healthy 
sensitized controls. Swamanthan et al., (1999) showed that M.tuberculosis-stimulated PBMC, 
from children with TB, produced less IFN-y compared to controls, whereas IL-12, IL-4 and 
IL-10 production was similar between the two groups. Studies conducted in young BCG- 
vaccinated infants in the Gambia have shown that their PBMC are capable of producing IFN- 
y after in-vitro stimulation with BCG (Marchant et al., 1999).
As so little is known about cellular immune responses in children with TB, it is vital that 
more studies be conducted. In addition, no studies on cellular immune responses in children 
who have completed TB therapy have been published. This information could be important 
with respect to the reactivation of latent TB.
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1.3.3.3 Differences in clinical manifestations of TB disease
In children, TB disease is usually the result of first contact with the M.tuberculosis bacillus 
(primary TB), while in adults, disease (postprimary TB) is thought to be due to reactivation 
o f a latent infection (the Koch phenomenon). Children younger than the age of 12 years 
usually present with primary TB. Most often the disease is a complication o f enlarged hilar 
and paratracheal lymph nodes which could cause local compression of a lung segment and /or 
ulcerative erosion o f the bronchi. Complications of disseminated disease, such as miliary TB 
and tuberculous meningitis occur most commonly under the age of five. During adolescence 
the clinical manifestations of the disease change to adult type chronic pulmonary TB. More 
pronounced systemic effects such as severe weight loss, high fever, tissue necrosis and the 
development of cavities characterize this form of the disease. Postprimary TB develops either 
from reactivation of dormant bacilli or by re-infection from a new contact. The change from 
primary to post-primary TB in adolescence has been hypothesized to be due to hormones, but 
this is still under investigation (Donald and Beyers, 1996).
1.3.3.4 Differences in immunological components in TB disease
A number o f components of the immune system that may be important in host defense 
against M.tuberculosis differ in adults and infants. As already mentioned, chemotaxis of 
neonatal monocytes is depressed (Raghunathan et al., 1982) and monocyte recruitment into 
tissues is also decreased (Bullock et al., 1969). These defects may delay recruitment of 
activated cells to M.tuberculosis-infected sites. This delay would permit the bacillus to grow 
and thereby overwhelm early local host immune responses.
Less effective antigen presentation by dendritic cells in regional lymph nodes to naive T cells 
may also result in a delay of initiation o f T cell specific responses. This could result in 
decreased production of IFN-y, TNF-a and CD 40L, which in turn could limit macrophage 
activation, allowing increased replication o f the bacillus in these cells. Although many of 
these differences may be small on their own, the “cumulative” effect would result in an 
inefficient host response. Although there has been a considerable amount o f research in the 
developing immune response to mycobacterial disease in adults and animals, additional 
information regarding the host response in children is required.
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Therefore, while various components of the immune system are known to be different at 
different ages, information regarding the in-vitro production o f certain cytokines in children, 
compared to adults, is still either controversial or not documented at all. The final aim of this 
study was thus to quantify and compare in-vitro cytokine immune responses, as well as 
proliferative responses, in subjects of different ages.
The previous section has highlighted some of the knowledge and gaps in our understanding 
o f TB. This study aims to address some of the gaps in our knowledge, as outlined below:
1.4 HYPOTHESIS
1. The whole blood assay is a useful model to quantify cellular immune responses.
2. Cellular immune responses to mitogens (PHA) and mycobacterial antigens (PPD) can 
differ at different ages.
3. The immune responses o f patients with acute TB (at diagnosis, before treatment) may be 
different from patients with a history of TB (after treatment).
1.5 AIMS
1. Establish whole blood assay method in order to quantify cellular immune responses (by the 
measurement of proliferation as well cytokine production, in response to PHA and PPD).
2. Quantify and compare immune responses o f patients with a past history of TB and healthy 
Mantoux positive subjects of different ages.
3. Compare immune responses of TB patients before treatment (at diagnosis), to immune 
responses after TB treatment.
Stellenbosch University http://scholar.sun.ac.za/
27
CHAPTER 2 
MATERIALS AND METHODS 
2.1 REAGENTS
2.1.1 Tissue culture reagents
Tissue culture reagents were obtained as follows:
Rosewall Park Memorial Institute (RPMI) 1640 - GIBCO BRL, Grand Island, NY
L-Glutamine - 200mM- Highveld Biologicals, Kelvin, Johannesburg
Penicillin/streptomycin - lOmg/ml - Highveld Biologicals, Kelvin, Johannesburg
KSLMS Serum Free Medium - Highveld Biologicals, Kelvin, Johannesburg
P- Mercaptoethanol - Merck, Darmstadt, Germany
Phytohaemagglutinin (PHA) - Sigma Chemicals, St.Louis, Missouri, USA
Purified protein derivative (PPD) - a gift from Dr. S. Ress, Department o f Clinical
Immunology, University of Cape Town, South Africa
2.1.2 Radiochemicals
[methyl-3H] Thymidine ([3H] thymidine), specific activity 25Ci/mmol - AEC Amersham, 
Buckinghamshire, England
2.1.3 Media and buffers
RPMI tissue culture medium
500ml o f RPMI was supplemented with L-glutamine (2mM), penicillin/streptomycin 
(O.lmg/ml) and p-mercaptoethanol (0.02pM)
Phosphate buffered saline (PBS) - pH 7.3
136mM NaCL, 2.6mM KCL, 8mM Na2H P04, 1.4mM KH2P 0 4
Carbonate Buffer - pH 9.5 
30mM Na2C 0 3, 69mM NAHCO3
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Tris buffered saline (TBS) - pH 7.3 
20mM Tris, 150mM NaCL
2.1.4 Enzyme-linked immunosorbant assay (ELISA) Duoset kits
Each kit contained a capture antibody (mouse anti-human), a mass calibrated standard, a 
secondary biotinylated antibody (either rabbit, chicken or goat anti-human) and a peroxidase- 
labelled streptavidin reagent.
ELISA duoset kits were obtained as follows:
IFN-y, IL-2, TNF-a, IL-4 - Genzyme Corporation, USA 
IL-12p40, IL-10, TGF-P - R&D Systems Europe, Abingdon, UK
2.1.5 Analytical grade reagents
These reagents were obtained as follows:
Hydrochloric acid (HCL), Potassium chloride (KCL), Potassium di-hydrogen phosphate 
(KH2PO4), Sodium hydrogen carbonate (NaHCOs), Sulphuric acid (H2SO4) - BDH 
Chemicals, Poole, England
Bovine serum albumin (BSA), Tween 20 - Sigma Chemicals, St.Louis, Missouri, USA
Tris(hydroxylmethyl)aminomethane (Tris), Sodium chloride (NaCl), di-Sodium hydrogen 
phosphate (Na2HP04), di-Sodium carbonate (Na2CC>3) - Merck, Darmstadt, Germany
2.1.6 Other reagents
Insta-Gel Plus scintillation fluid - Packard Bioscience Company, Groningen, The Netherlands 
Tetramethylbenzidine/peroxide (TMB) substrate - Kirkegaard and Perry (KPL), Maryland, 
USA
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2.2 STUDY SUBJECTS
2.2.1 Setting
The majority o f participating individuals resided in two adjacent Cape Town suburbs, 
namely, Ravensmead and Uitsig. The remaining individuals resided in areas in close 
proximity to these suburbs. The TB notification rate in the Ravensmead and Uitsig 
communities is more than 700/100 000 (Beyers et al., 1996), representing a typical very high 
incidence community, characteristic o f those in the Western Cape.
2.2.2 Recruitment
The subjects of this study were recruited at the time of TB diagnosis in patients, from May 
1998 to November 1999 (for the “before therapy” study) and again approximately 1 year later 
(6 months after patients had completed TB therapy), from May 1999 to November 2000 (for 
this follow-up “after therapy” study). They were recruited from the local authority health 
clinics in the City o f Tygerberg (with permission from Doctor I. Toms, Head of Health 
Services, City o f Tygerberg) and the paediatric wards o f the Tygerberg Hospital (with 
permission from Professor P.B. Hesseling, Head of the department o f Paediatrics and Child 
Health).
2.2.3 Consent and ethical approval
Informed written consent was obtained from every subject 14 years and older or his/her 
guardian when the participant was younger than 14 years. All subjects volunteered to 
participate in this study and did not receive any compensation for participation. HIV-test 
counselling was given to each subject and his/herguardian.
The Ethics Committee, Faculty of medicine, University of Stellenbosch, has approved this 
study (registration number: 98/117).
2.2.4 Inclusion criteria
I. A) Patients with TB (before commencement of TB therapy):
- TB patients were recruited before initiation of treatment. No patient was known 
to have any disease other than TB or was on treatment with corticosteroids at the 
time o f recruitment
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- After diagnosis o f TB, the patients were treated with standard combination 
therapy under direct supervision (DOTS) in accordance with the South African 
National TB Control Programme (South African TB Control Programme, 
February 1996)
- A case o f TB fulfilled one of the following criteria:
A positive sputum-smear for acid-fast bacilli and symptoms of TB 
A positive culture for M.tuberculosis in sputum, gastric aspirate 
cerebrospinal fluid or lymph node in a person with symptoms of TB 
A history of a recent contact with a known and identified TB patient in 
combination with signs of TB on the chest radiograph and clinical 
symptoms of TB (cough, weight loss)
B) Patients with TB (after completion of TB therapy):
Successful completion of a full course o f combination TB therapy (with a 
negative Ziehl Neelsen (ZN) stain for M.tuberculosis in adolescent and 
adult patients)
II. Healthy control subjects who had a positive tuberculin skin test (Mantoux):
- A person with a Mantoux skin test induration > or equal to 15mm and no 
recent history or clinical symptoms of any disease
- A chest radiograph (CR) was evaluated upon entry to the study to exclude 
radiological signs of TB disease for all persons under the age of 12 years
- In accordance with the South African National TB Control Programme, all 
healthy Mantoux positive children under the age of five, who were living in 
the same house as a patient with TB disease, received supervised 
prophylactic treatment
2.2.5 Exclusion criteria
The exclusion criteria for subjects to enter the study were:
- Previous TB treatment, including prophylactic chemotherapy
- Numerous periods (>3/year) o f purulent otorrhea
Skin infection with scabies or eczema at the time o f recruitment
- Asthma, if  on treatment with oral steroids during the previous 3 months
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- Measles during the previous 3 months or a measles contact (2 weeks prior 
to recruitment)
- Chickenpox or chickenpox contact (3 weeks prior to recruitment)
- Oral or intramuscular hormonal contraception
Pregnancy and the 3 month period after giving birth, if  breastfeeding
- Known immunodeficiency or a positive HIV -1 /HIV-2 test 
Signs of any overt infection other than TB
Fever (>38°C) and /or malnutrition
2.3 METHODS
2.3.1 Treatment of patients
Children diagnosed with TB were treated with daily isoniazid, rifampicin and pyrazinamide 
for 4 months while adult patients received all the afore-mentioned drugs plus ethambutol, 
administered daily for 2 months, followed by a 4 month continuation phase of isoniazid and 
rifampicin, administered twice weekly. To confirm cure, sputa from adolescent and adult 
patients were tested for presence of M. tuberculosis by ZN staining.
2.3.2 Tuberculin skin testing (Mantoux)
0.1ml (5TU) tuberculin (Japan BCG Laboratory) was injected intradermally by trained 
healthcare workers. The size o f the transverse induration was read 48-72 hours after 
administration and an area of >15mm was regarded as positive.
2.3.3 Whole blood culture
Blood was collected (5ml in a sodium heparin tube) from subjects between 9.00 and 12.00am 
and transported to the laboratory at room temperature. All blood was processed under laminar 
flow conditions within 2-3 hours of venous puncture.
Blood was diluted 1:10 in RPMI and 180pl/well was pipetted (in triplicate for proliferation 
studies and quadruplicate for harvesting o f supernatant fluid for cytokine analysis) into 96- 
well, U-bottom plates (Coming Costar, Cambridge, MA). Twenty jj.1 of the polyclonal 
stimulant, PHA (diluted to a final concentration of lOfig/ml in RPMI), or 20|a.l of the specific 
mycobacterial antigen, PPD (diluted to a final concentration o f 3.3jag/ml in RPMI), was 
added to each well serving as a stimulated culture, while cultures incubated with RPMI alone
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served as negative controls. All cultures were subsequently placed in a humidified 5% C02, 
37°C incubator.
PHA- and PPD- stimulated cells were cultured for a maximum of 4 and 7 days respectively, 
depending on the optimum time of proliferation and cytokine production.
2.3.4 Proliferation assay
•  •  T » 1  •  3Cellular proliferation was assessed by [ H] thymidine uptake. This assay measures [ H]
thymidine uptake into the DNA of dividing cells and is a commonly used method for
assessing cellular proliferation. Diluted blood (section 2.3.3) was cultured in triplicate with
RPMI (negative control), PHA (final concentration: 10|j.g/ml) and PPD (final concentration:
3,3p.g/ml) for 3 and 6 days respectively, before pulsing by the addition of [3H] thymidine
(0.5|jC  i/well) for 20 hours. Thereafter, each culture was transferred into a well in a 96-well
fiat-bottom plate and frozen. When sufficient assays were accumulated, the frozen plates
were allowed to thaw at room temperature and transported to the cell harvester which was
located in the department of Microbiology at Tygerberg hospital. Thereafter, non-soluble
radioactivity was precipitated with a Skatron Cell Harvester (Flow Laboratories, Bonn) onto
glass fiber filter mats (Macherey-Nagel, Germany), dried and immersed in scintillation fluid.
Radioactivity was subsequently read on a P-scintillation counter (Beckman multi-purpose
scintillation counter, Beckman Instuments, Fullerton, CA) and expressed as counts per
minute (cpm). Triplicate cpm readings were averaged and background from unstimulated
cultures was subtracted from stimulated cultures.
2.3.5 Harvesting of supernatant fluid (SNF) for cytokine analysis
SNF from cultures was carefully removed (harvested) from each well, taking care not to 
disturb the sedimented red blood cells. The harvested SNF from each identical well was then 
pooled, mixed, aliquotted and frozen at-20°C for subsequent measurement of IFN-y, TNF-a, 
IL-10, IL-12p40, IL-2 and TGF-P levels by ELISA. The harvesting procedure was performed 
at various time points for the different cytokines (Table 2.1) as was determined in 
optimization studies (section 3.1.4).
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Table 2.1
Harvesting time points of SNF for cytokine assays
Cytokine PHA PPD
IFN-y Day 4 Day 7
IL-2 Day 3 Day 3
IL-12 Day 4 Day 7
IL-10 Day 3 Day 7
TNF-a Day 3 Day 7
TGF-p Day 4 Day 7
2.3.6 ELISA
A sandwich ELISA was used to quantify levels of cytokines in culture SNF. Briefly, lOOpl of 
capture antibody (see table 3.19 for concentration), diluted in carbonate buffer (pH 9.5), was 
coated onto the wells of a 96-well maxisorb microtiter plate (Nunc) by overnight incubation 
at 4°C. After washing in PBS containing 0.05% Tween 20 (wash buffer), free antibody 
binding sites were blocked. This was done by adding 250pl o f blocking buffer (PBS 
containing 1% BSA) to each well. Blocking buffer was then discarded and 100(j.l of serially 
diluted recombinant standard or sample (see Table 2.2 for dilutions) was added in duplicate 
(samples for TGF-P analysis were first transiently treated with hydrochloric acid in order to 
release TGF-P from it’s noncovalent association with latency-associated peptide).
Table 2.2
Dilutions for samples for measurement of cytokines with ELISA
Cytokine PHA PPD
IFN-y Subjects < 12 yrs -  1:20 
Subjects > 12 yrs -  1:40
Subjects < 12 yrs -  1:20 
Subjects > 12 yrs -  1:40
IL-2 1:2 1:2
IL-12 1:2 1:2
IL-10 1:10 1:2
TNF-a 1:10 1:5
TGF-p 1:2.8 1:2.8
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The specific cytokine, if  present, binds to the capture antibody on the micro-titer plate. 
Thereafter, plates were washed with wash buffer (see above) and lOOp.1 of secondary 
biotinylated antibody which was diluted in PBS containing 1% BSA and 0.05% Tween 20 
was added (see table 3.20 for concentration). This antibody binds to the captured cytokine. 
Unbound secondary antibody was washed off with wash buffer (see above) and 100(4.1 of 
peroxidase-labelled streptavidin reagent was added. This reagent attaches to biotin in the 
immune complex. Plates were again washed with wash buffer and IOOjj.1 of TMB substrate 
solution was added, which produces a blue color in the presence of peroxidase. The colour 
reaction was stopped after 10 minutes by the addition o f lOOpl of 2N H2SO4, which changes 
the blue colour to yellow. The intensity o f the yellow colour is proportional to the amount of 
cytokine present in the standards or samples. The absorbance o f each well was read at 450nm 
(A450) on a Titertek spectrophotometer and the background values (obtained from the A450 of 
the zero standard) were subtracted from all the values. A standard curve was constructed 
using Prism graph pad software, by plotting the mean, background-subtracted absorbance for 
each standard on the vertical axis (y-axis) versus the corresponding standard concentration on 
the horizontal axis (x-axis). The software package automatically calculated the concentration 
of the unknown samples from the standard curve. The lower limits of detection for all the 
cytokines were 15pg/ml. If the absorbance o f the undiluted sample fell below the absorbance 
of 15pg/ml, the concentration was calculated using the formula: X=Y.KD/Bmax-Y 
(Y=absorbance o f sample; Bmax and KD values were automatically calculated by the 
software package). Figure 2.1 depicts a typical standard curve used for the calculation of the 
cytokine concentrations in the samples.
Figure 2.1
Example of a typical standard curve used for calculation of unknown cytokine 
concentrations
IFN-y (pg/ml)
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2.3.7 Statistical analysis
Statistical analysis was performed using SPSS software. Since the variables tested did not 
show a normal distribution, they were compared by the non-parametric Mann-Whitney U test 
for the comparison of 2 independent groups, and the Wilcoxon test, for the comparison of 2 
related samples. Correlation analysis was conducted using Spearman rank correlation 
coefficient test. P values o f <0.05 were considered significant.
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CULTURE AND ELISA CONDITIONS
3.1 Optimization of whole blood culture conditions
3.1.1 Background
Most investigators have traditionally used isolated peripheral blood mononuclear cells 
(PBMC) for the in-vitro analysis of proliferative and cytokine responses by human cells. 
More recently, diluted whole blood has been used to analyse these responses, (Weir et al., 
1994; Elliot et al., 1999; van Crevel et al., 1999) which have been shown to parallel those 
obtained using PBMC (Weir et al., 1994; De Groote et al., 1992). Whole blood assays 
(WBA) have a number of advantages over PBMC cultures. These include: 1) only a small 
volume o f blood is required, 2) the WBA is rapid and simple, 3) no unphysiological cell 
separation is involved and 4) there is no requirement for FCS which is known to contain 
TGF-P and growth factors produced by platelets that could alter T cell cytokine responses in 
vitro (Daynes et al., 1992). Furthermore, investigators have demonstrated that erythrocytes 
and neutrophils, which are not present in PBMC cultures, can provide supplementary 
cytokines and factors that contribute to lymphocyte and monocyte responses (Kalechman et 
al., 1993; Van der Pouw Kraan et al., 1995).
Since the WBA was not established in our laboratories, the work described in this section was 
done to set up the assay and establish optimal conditions. In order to do this, it was necessary 
to compare a number of factors, for example, two available cell culture media, namely, RPMI 
and KSLMS (KSLMS was previously used by another researcher in the laboratory). Whole 
blood proliferative responses (see section 2.3.4), in the absence and presence of stimulants 
(PHA: 10|ag/ml and PPD: 3.3 (J.g/ml) were therefore compared over time, using the two 
different media.
In these experiments, after the cultures were pulsed with 3H thymidine, they were 
immediately transported to the only available cell harvester, which was located in the 
Department o f Microbiology at Tygerberg Hospital (approximately 1 km away). Non-soluble
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3H thymidine was precipitated onto glass fibre filters by the cell harvester, dried, placed into 
scintillation fluid and counted. Because o f the distant location of the harvester it was decided 
to evaluate whether freezing and later thawing of the cultures (approximately 1 week), before 
harvesting on the harvester, would influence the results. Another proliferation assay, over 
time, in the absence and presence of PHA (10(j.g/ml) was therefore performed.
The measurement o f cytokine levels following PHA- and PPD-stimulation, was also 
controversial with respect to time points for supernatant fluid harvesting (Barnes et al.,1993; 
Zhang et al., 1994). Furthermore, it was not known whether the kinetics o f cytokine 
production in children is different from that of adults. A WBA over time, to determine the 
optimum harvesting time points of supernatant fluid, was thus done on blood obtained from 
four individuals. These individuals included two patients diagnosed with TB (1 child, aged 3, 
and 1 adult) and two Mantoux positive individuals (both adults).
3.1.2 Comparison of proliferative responses using RPMI and KSLMS
Heparinised blood was obtained from a healthy volunteer and diluted 1:10 with either RPMI 
or KSLMS. Diluted blood was plated, in triplicate, into a 96-well round bottom plate and 
stimulated with PHA or PPD for 5 and 7 days respectively (section 2.3.3). PHA and PPD 
were both diluted in RPMI to give final concentrations of 10|ag/ml and 3.3|jg/ml respectively. 
Blood incubated with medium alone served as a negative control. Proliferative responses 
were measured daily by 3H thymidine incorporation (section 2.3.4) and results were 
expressed as cpm stimulated minus unstimulated cultures (means o f triplicate cultures).
Table 3.1 and Figure 3.1 shows the respective results and kinetic curves following PPD 
stimulation. As seen in Table 3.1 and Figure 3.1 proliferative responses for the two media 
showed similar results and kinetic curves.
(Note: the experiment was performed twice and results are from one representative 
experiment).
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Table 3.1
PPD-stimulated proliferative response of whole blood diluted in RPMI and KSLMS 
media, over time
Results are expressed as mean cpm of stimulated cultures (triplicate measurements) minus 
mean cpm of unstimulated cultures (triplicate measurements)
Day RPMI (cpm) KSLMS (cpm)
1 -140 -79.0
2 1023 1203
3 6373 6171
4 15593 14644
5 38725 39512
6 79131 48013
7 74358 77991
Figure 3.1
PPD-stimulated proliferative response of whole blood diluted in RPMI and KSLMS 
media, over time
Results are expressed as mean cpm of stimulated cultures (triplicate measurements) minus 
mean cpm of unstimulated cultures (triplicate measurements)
RPMI
KSLMS
Day
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Table 3.2 and Figure 3.2 show the respective results and kinetic curves following PHA 
stimulation. As seen in Table 3.2 and Figure 3.2, proliferative responses for the two media 
showed equivalent results and kinetic curves. There was no result available for day 5 for 
blood diluted in KSLMS due to a technical problem. (Note: the experiment was performed 
twice and results are from one representative experiment).
Table 3.2
PHA-stimulated proliferative response of whole blood diluted in RPMI and KSLMS 
media, over time
Results are expressed as mean cpm of stimulated cultures (triplicate measurements) minus 
mean cpm of unstimulated cultures (triplicate measurements)
Day RPMI (cpm) KSLMS (cpm)
1 -2 -1
2 30990 26230
3 59429 68145
4 91550 88022
5 117486 Technical error
Figure 3.2
PHA-stimulated proliferative response of whole blood diluted in RPMI and KSLMS 
media, over time
Results are expressed as mean cpm of stimulated cultures (triplicate measurements) minus 
mean cpm of unstimulated cultures (triplicate measurements)
RPMI
KSLMS
Day
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3.1.3 Evaluation of the freeze/thaw process on proliferative responses
Heparinised blood was obtained from the same volunteer whose blood was used for the 
experiment described in section 3.1.2 and diluted 1:10 with RPMI. Diluted blood 
(180|il/well) was cultured (in triplicate wells) with PHA (10^g/ml). Blood incubated with 
medium alone served as a negative control. Each day the cultures were pulsed by the addition 
of [3H] thymidine (0.5jiCi/well) for 20 hours. The experiment was performed in duplicate, 
whereby, each day, after the 20 hour incubation with 3H thymidine, one assay was harvested 
onto the glass fiber filters and transported to the cell harvester for harvesting immediately, 
while the other was transferred into wells of a 96-well flat-bottom plate and frozen. When 
both assays were complete, the cultures that had been transferred into flat-bottom plates and 
frozen were allowed to thaw at room temperature and then transported to the harvester for 
harvesting. After harvesting, the filters were dried, placed into scintillation fluid and counted 
on a P-scintillation counter as previously performed. Results for proliferative responses were 
expressed as mean cpm of triplicate stimulated minus unstimulated cultures.
Table 3.3 and Figure 3.3 show the respective results and kinetic curves following PHA 
stimulation. The results suggest that proliferative responses of the frozen/thawed cultures 
were similar (except for day 4) to proliferative responses of cultures that were harvested 
immediately. There was no result available for day 5 for freshly harvested cultures due to a 
technical problem.
The freeze/thaw process did not appear to have a dramatic effect on the proliferative 
responses, therefore, for reasons of scale and economy, it was decided to include this 
procedure in the method.
3.1.4 Determination of optimal harvesting time points of supernatant fluid for 
cytokine analysis
Heparinised blood was obtained from four individuals, which included two patients 
diagnosed with TB from the Ravensmead/Uitsig communities (1 child and 1 adult) and two 
Mantoux-positive individuals (both adults). One Mantoux-positive individual was a healthy 
laboratory volunteer (Man pos 1) and the other was an individual from the Uitsig community 
(Man pos 2). Blood was diluted 1:10 with RPMI and plated in multiple wells, into a 96-well 
round bottom plate. Samples were stimulated with PHA (10|j,g/ml) and PPD (3.3|xg/ml) for 5
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Table 3.3
PHA-induced proliferative responses of frozen/thawed cultures compared to freshly 
harvested cultures
Results are expressed as mean cpm of stimulated cultures (triplicate measurements) minus 
mean cpm of unstimulated cultures (triplicate measurements)
Day Freshly harvested cultures 
(cpm)
Frozen/thawed cultures 
(cpm)
1 38 141
2 41223 38225
3 46415 39473
4 53805 93302
5 Technical error 69911
Figure 3.3
Time course of PHA-stimulated proliferative responses of frozen/thawed cultures 
compared to freshly harvested cultures
Results are expressed as mean cpm of stimulated cultures (triplicate measurements) minus 
mean cpm of unstimulated cultures (triplicate measurements)
—— Frozen/thawed 
—*— Harvested immediately
6
75000-
& 50000-
25000
day
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and 7 days respectively (section 2.3.5). Blood incubated with medium alone served as a 
negative control. Each day the supernatant fluid of identical stimulants was harvested (section 
2.3.5), pooled, mixed, aliquotted and frozen until assayed for cytokine levels by ELISA. The 
cytokines measured included IFN-y, IL-2, TGF-p, IL-12, IL-10, TNF-a and IL-4. Results are 
expressed in pg/ml of cytokine (value for stimulated cultures minus value for unstimulated 
cultures).
Note: for comparison and reference, all cytokine data (tables and figures) are grouped 
together at the end of this section.
IFN-y
Table 3.4 and Figure 3.4 show levels of IFN-y production of PPD-stimulated cultures for all 
four individuals, over time. As seen in Table 3.4 and Figure 3.4, the general trend observed 
for the three adults was a steady increase of production of IFN-y levels until a time point 
between day 3 and day 5, after which a plateau was reached. One Mantoux-positive subject 
(Man pos 1) demonstrated peak concentration levels on day 3 (10659pg/ml), a second 
Mantoux-positive subject (Man pos 2) on day 4 (26056pg/ml) and the adult with TB on day 5 
(22763 pg/ml). The child produced consistently low levels of IFN-y throughout, only 
reaching a maximum of 3658pg/ml on day 7.
PHA-induced IFN-y levels for Man pos 1 and Man pos 2 peaked on day 2 (11290 pg/ml ) and 
day 4 (28389 pg/ml ) respectively, and then plateaued (Table 3.5 and Figure 3.5). The adult 
with TB demonstrated peak concentration levels on day 3 (13575pg/ml), remained consistent 
at day 4 (14325pg/ml), and declined on day 5. The child produced maximum levels of 5768 
pg/ml IFN-y on day 3, after which levels decreased.
Background counts were minimal for Man pos 1 and the child with TB throughout the time 
courses, but Man pos 2 and the adult with TB showed initial background counts in 
unstimulated cultures similar to stimulated cultures, when stimulation was not yet optimal. 
The counts in unstimulated cultures did not subsequently increase at later time points, as 
opposed to stimulated cultures, but remained at those levels.
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PPD-stimulated IL-2 production for all individuals was extremely variable over time (Table 
3.6 and Figure 3.6). Generally, except for Man pos 1, levels were very low. Since IL-2 levels 
are very low, variations may possibly be artefacts or concentrations may be regarded as 
background values.
PHA-stimulated IL-2 production for all individuals was marginally higher than PPD-induced 
IL-2, but also variable over time (Table 3.7 and Figure 3.7). Man pos 1 already demonstrated 
maximal levels at day 1 (833pg/ml) after which the concentration of IL-2 showed a steady 
decline. Man pos 2 levels increased till day 3 (656pg/ml) and then diminished. IL-2 levels of 
the adult with TB demonstrated peak concentration levels between day 3 (344pg/ml) and day 
4 (266pg/ml) and then declined, while the child with TB demonstrated peak concentration 
levels on day 2 (439pg/ml) with a subsequent decrease.
Background counts from unstimulated cultures were generally low, with the child producing 
slightly higher counts from unstimulated cultures.
TGF-(3
PPD-stimulated TGF-P production for all individuals was variable over time (Table 3.8 and 
Figure 3.8). Man pos 1 demonstrated peak concentration levels on day 4 (1505pg/ml), which 
subsequently declined and then showed a second peak on day 7 (1589pg/ml). Man pos 2 
demonstrated a similar trend to Man pos 1, but at a slightly lower concentration. The adult 
with TB produced the highest levels of TGF-P, increasing until day 6 (3638pg/ml) and 
declining to 1857pg/ml at day 7. The child with TB demonstrated fluctuating levels, showing 
a peak on day 2 (686pg/ml) and another at between day 4 (687pg/ml), which was sustained 
till day 6 (593pg/ml), and subsequently declined on day 7 (Opg/ml).
PHA-stimulated TGF-P production for all individuals was also variable over time (Table 3.9 
and Figure 3.9). Levels for Man pos 1 increased steadily from day 1 (450pg/ml) to reach a 
peak on day 5 (2051pg/ml) while Man pos 2 already produced maximal levels on day 1 
(1288pg/ml), declined till day 3 (Opg/ml) and then recovered to reach 362pg/ml at day 5. 
TGF-P levels in the adult with TB peaked between day 2 (1046pg/ml) and day 3 
(1243pg/ml), whereafter it declined. TGF-P levels in the child with TB had a peak value of
IL-2
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3726pg/ml on day 2 which declined to day 4 (471pg/ml) and then showed a slight increase on 
day 5 (927pg/ml).
Background counts for unstimulated cultures were high for all subjects throughout both time 
courses.
IL-12
All individuals, except for the child had well-maintained levels of IL-12 throughout the 7-day 
period (Table 3.10 and Figure 3.10). Man pos 1 had the highest values of the adults, with 
levels already at 3906pg/ml on day 1. The levels peaked at between day 2 (5296pg/ml) and 
day 3 (5465pg/ml) and showed a second peak on day 5 (5637pg/ml), whereafter IL-12 
concentration showed a slight decline. Man pos 2 and the adult with TB had very similar 
trends with both producing good levels at day 1 (2253 and 1450pg/ml respectively). 
Thereafter, levels declined slightly, with Man pos 2 demonstrating peak concentration levels 
at day 4 (3034pg/ml) and the adult with TB producing highest levels at day 5 (1989pg/ml). 
Both declined slightly till day 7. The child with TB had lower levels compared to the adults, 
peaking with a value of 971pg/ml on day 3 and remaining more or less at those levels for the 
rest of the time course.
The kinetics of PHA-stimulated IL-12 production for all individuals was similar (Table 3.11 
and Figure 3.11). Man pos 1 showed a gradual increase in levels until reaching a peak at day 
4 (2056pg/ml) and subsequently plateaued. Man pos 2 and the child with TB also showed a 
similar gradual increase in levels, which peaked at day 5 (1017 and 793pg/ml respectively). 
The adult with TB had maximal production of 656pg/ml on day 4, but levels declined slightly 
thereafter.
Background counts from unstimulated cultures were moderate for all subjects, except for 
Man pos 1, who produced none at all.
TNF-a
Generally, PPD-induced levels were very low for all subjects. The kinetics of PPD-stimulated 
TNF-a production for Man pos 1 and the child with TB were similar, with both showing 
initial maximal values of 128 and 40pg/ml respectively (Table 3.12 and Figure 3.12). 
Thereafter, values showed a steady decline throughout the rest of the 7-day period. The
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values for the child were much lower than those of the adults. Man pos 2 had a peak value of 
321pg/ml at day 2 and a second peak at day 6 with a value of 256 pg/ml. The adult with TB 
had a concentration of 269pg/ml on day 1, whereafter levels declined until day 3 (96pg/ml) 
and subsequently increased steadily to peak at day 7 with a value of 406pg/ml.
Man pos 1 and the adult with TB showed similar trends for the PHA-stimulated time courses 
(Table 3.13 and Figure 3.13). Both had gradual increases in concentration to reach peak 
values of 808 and 340pg/ml respectively, on day 3. Man pos 2 also had a similar trend, but 
peaked with a value of 762pg/ml on day 4. The child with TB already had maximal levels on 
day 1 (339pg/ml), where after levels declined for the rest of the 5-day period.
Background counts from unstimulated cultures were minimal for all subjects.
IL-10
The kinetics of PPD-stimulated IL-10 for all individuals was extremely variable (Table 3.14 
and Figure 3.14). Man pos 1 showed maximal concentration at day 5 with a value of 402, 
while Man pos 2 already produced maximal levels at day 2 (lllOpg/ml). The adult with TB 
produced high levels on day 1 (457pg/ml) which declined and subsequently increased again 
on day 7 (584pg/ml) while the child with TB had a maximum level on day 2 (376pg/ml) and 
another on day 6 (396pg/ml).
PHA-induced IL-10 was also variable for all individuals (Table 3.15 and Figure 3.15). Man 
pos 1 demonstrated a peak concentration value of 7037pg/ml on day 3, while Man pos 2 
showed maximal concentration on day 2 (2868pg/ml) and then again on day 4 (3697pg/ml). 
The adult with TB produced consistently low amounts of IL-10 throughout the 5-day period, 
only reaching a maximal value of 620pg/ml on day 4. The child with TB showed maximal 
concentration of 2002pg/ml already at day 2, where after levels decreased and remained low 
throughout the rest of the time course.
Background counts from unstimulated cultures were moderate for all subjects.
IL-4
Levels of PPD-induced IL-4 were extremely low for all individuals throughout the 7-day 
period (Table 3.16 and Figure 3.16).
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In general, levels of PHA-induced IL-4 were slightly higher than those found with PPD 
stimulation (Table 3.17 and Figure 3.17). Man pos 1 produced a high concentration of IL-4, 
showing maximal concentration on day 3 (238pg/ml), while Man pos 2 levels were much 
lower, peaking at day 2 (56pg/ml) and at day 4 (41pg/ml). The adult with TB had consistently 
low levels throughout while the child only produced a maximum of 35pg/ml on day 1.
Background counts from unstimulated cultures were minimal for all subjects.
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Table 3.4
PPD-stimulated IFN-y production of four subjects, over time
Results are expressed in pg/ml of IFN-y
U - unstimulated; S - stimulated; S -U  - stimulated minus unstimulated
IVIan Pos 1 Man Pos 2 T B Adult T B Chi d
Day U S S - U U S S - U U S S - U U S S - U
1 43 1858 1815 991 2624 1633 2348 1948 0 157 170 13
2 0 5552 5552 1136 12424 11288 960 3573 2613 115 395 280
3 47 10706 10659 1658 17280 15622 1298 7985 6687 97 492 395
4 67 9612 9545 1291 27347 26056 873 14573 13700 67 1052 985
5 67 11325 11258 1902 28591 26689 1135 23898 22763 80 1092 1012
6 0 9765 9765 1202 28313 27111 898 21910 21012 162 1917 1755
7 76 11325 11249 1713 28213 26500 1523 24998 23475 130 3787 3657
Figure 3.4
PPD-stimulated IFN-y production of four subjects, over time
Results are expressed in pg/ml of IFN-y (stimulated cultures minus unstimulated cultures).
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Table 3.5
PHA-stimulated IFN-y production of four subjects, over time
Results are expressed in pg/ml of IFN-y
U - unstimulated; S - stimulated; S - U - stimulated minus unstimulated
Man Pos 1 Man Pos 2 T B Adult T B Chi d
Day U S S -U U S S -U U S S -U U S S -U
1 21 1313 1292 980 15680 14700 1535 1298 0 85 3415 3330
2 34 11324 11290 1113 20736 19622 948 1310 36 67 5720 5653
3 0 10359 10359 3024 28502 25478 610 14185 13575 247 6015 5768
4 267 11324 11057 1536 29924 28388 1435 15760 14325 152 1072 920
5 39 11325 11286 1336 29336 28000 1035 2385 1350 112 1350 1238
Figure 3.5
PHA-stimulated IFN-y production of four subjects, over time
Results are expressed in pg/ml of IFN-y (stimulated cultures minus unstimulated cultures).
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Table 3.6
PPD-stimulated IL-2 production of four subjects, over time
Results are expressed in pg/ml of IL-2
U - unstimulated; S - stimulated; S -U  - stimulated minus unstimulated
Mein Pos 1 Man Pos 2 TB AdiLilt TB Child
Day U S S- U u s S- U u s S- U u S S - U
1 16 414 398 0 29 29 0 0 0 76 55 0
2 0 162 162 100 20 0 0 102 102 12 112 100
3 0 77 77 0 89 89 0 48 48 35 63 28
4 0 12 12 14 0 0 0 40 40 20 192 172
5 0 14 14 0 0 0 99 163 64 43 41 0
6 0 373 373 52 0 0 0 0 0 4 102 98
7 0 22 22 10 70 60 0 0 0 76 60 0
Figure 3.6
PPD-stimulated IL-2 production of four subjects, over time
Results are expressed in pg/ml of IL-2 (stimulated cultures minus unstimulated cultures).
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Table 3.7
PHA-stimulated IL-2 production of four subjects, over time
Results are expressed in pg/ml of IL-2
U - unstimulated; S - stimulated; S - U  - stimulated minus unstimulated
Mein Pos 1 Ma n Pos 2 TB Adu t TB Child
Day U S S- U U S S- U U s S - U U S S - U
1 0 833 833 51 260 209 0 0 0 19 293 274
2 25 800 775 0 312 312 0 9 9 19 458 439
3 0 475 475 115 771 656 0 344 344 0 283 283
4 0 205 205 0 333 333 0 266 266 48 37 0
5 0 339 339 113 122 10 15 0 0 8 138 130
Figure 3.7
PHA-stimulated IL-2 production of four subjects, over time
Results are expressed in pg/ml of IL-2 (stimulated cultures minus unstimulated cultures). 
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Table 3.8
PPD-stimulated production of TGF-P four subjects, over time
Results are expressed in pg/ml of TGF-P
U - unstimulated; S - stimulated; S - U  - stimulated minus unstimulated
Mein Pos 1 Main Pos 2 TB Adu t TB Chil<i
Day U s S -U U S S -U U S S -U U S S -U
1 519 591 72 2008 2200 192 5304 6263 959 2397 2582 185
2 346 1022 676 3066 3119 53 7083 7652 569 2935 3621 686
3 707 1843 1136 2773 3176 403 6601 7443 843 4075 3894 0
4 1202 2707 1505 2877 3287 410 6751 8045 1294 3855 4542 687
5 1360 1900 539 3376 2773 0 7744 10500 2756 4704 5257 553
6 1471 2261 790 2550 2539 0 7946 11584 3638 2216 2809 593
7 1159 2748 1589 2459 3757 1298 8770 10627 1857 2061 1214 0
Figure 3.8
PPD-stimulated TGF-P production of four subjects, over time
Results are expressed in pg/ml of TGF-P (stimulated cultures minus unstimulated cultures). 
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Table 3. 9
PHA-stimulated production of TGF-P four subjects, over time
Results are expressed in pg/ml of TGF-p
U - unstimulated; S - stimulated; S -U  - stimulated minus unstimulated
Msin Pos 1 Main Pos 2 TB Adu t TB Chil<i
Day U S S - U u S S- U U S S - U U S s - u
1 335 785 450 292 1580 1288 5646 5056 0 2284 3841 1557
2 420 988 568 2388 1915 0 5257 6303 1046 471 4198 3727
3 464 1471 1007 3157 2363 0 6538 7781 1243 2917 4242 1325
4 743 2144 1401 2431 2438 7 7414 7867 453 4051 4522 471
5 827 2878 2051 2652 3013 361 7836 6882 0 3645 4571 926
Figure 3.9
PHA-stimulated TGF-P production four subjects, over time
Results are expressed in pg/ml of TGF-P (stimulated cultures minus unstimulated cultures).
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Table 3.10
PPD-stimulated IL-12 production of four subjects, over time
Results are expressed in pg/ml of IL-12
U - unstimulated; S - stimulated; S -U  - stimulated minus unstimulated
Man Pos 1 Main Pos 2 TB Adu t TBI Chi d
Day u s S -U U S S -U U S S -U U S S -U
1 0 3906 3906 2043 4296 2253 438 1888 1450 1181 924 0
2 0 5296 5296 1808 3646 1838 424 1763 1339 670 1374 704
3 0 5465 5465 1521 3471 1950 495 1334 839 849 1820 971
4 0 4602 4602 1933 4968 3035 370 1980 1610 727 1659 932
5 0 5637 5637 1849 4389 2540 495 2484 1989 649 1138 489
6 0 4668 4668 2514 5005 2491 449 2374 1925 431 1013 582
7 0 4846 4846 2539 3427 888 356 1406 1050 834 1702 868
Figure 3.10
PPD-stimulated IL-12 production of four subjects, over time
Results are expressed in pg/ml of IL-12 (stimulated cultures minus unstimulated cultures) 
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Table 3.11
PHA-stimulated IL-12 production of four subjects, over time
Results are expressed in pg/ml of IL-12
U - unstimulated; S - stimulated; S -U  - stimulated minus unstimulated
Mein Pos 1 Man Pos 2 TB Adu t TB Child
Day U s S - U U S S - U U S S - U U S S - U
1 0 753 753 1070 1242 172 386 505 119 945 645 0
2 0 984 984 740 1349 609 321 968 647 741 527 0
3 0 1759 1759 1059 1454 395 352 911 559 741 916 175
4 0 2056 2056 1010 1638 628 280 936 656 834 1131 296
5 0 2031 2031 1000 2017 1017 502 671 169 641 1434 793
Figure 3.11
PHA-stimulated IL-12 production of four subjects, over time
Results are expressed in pg/ml of IL-2 (stimulated cultures minus unstimulated cultures).
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Table 3.12
PPD-stimulated TNF-a production of four subjects, over time
Results are expressed in pg/ml of TNF-a
U - unstimulated; S - stimulated; S - U  - stimulated minus unstimulated
Mein Pos 1 Man Pos 2 TB Adu t TB Chil<i
Day U S S -U u S S -U U s S -U U s s -u
1 0 128 128 11 115 104 21 290 269 45 85 40
2 0 81 81 23 344 321 0 152 152 7 13 6
3 0 92 92 25 151 126 0 96 96 0 14 14
4 0 76 76 19 151 132 0 176 176 0 3 3
5 0 85 85 0 234 234 0 181 181 0 0 0
6 0 75 75 0 256 256 0 254 254 0 6 6
7 14 80 66 0 122 122 0 406 406 0 16 16
Figure 3.12
PPD-stimulated TNF-a production of four subjects, over time
Results are expressed in pg/ml of TNF-a (stimulated cultures minus unstimulated cultures).
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Table 3.13
PHA-stimulated TNF-a production of four subjects, over time
Results are expressed in pg/ml of TNF-a
U - unstimulated; S - stimulated; S -U  - stimulated minus unstimulated
Mein Pos 1 Main Pos 2 TB Adu t TB Chilei
Day U s S -U U S S -U U s S -U U s S-U
1 0 287 287 44 447 403 0 30 30 43 382 339
2 0 736 736 0 525 525 0 52 52 0 207 207
3 0 808 808 85 771 686 0 340 340 0 139 139
4 0 405 405 0 762 762 0 307 307 0 0 0
5 0 418 418 0 539 539 0 0 0 0 0 0
Figure 3.13
PHA-stimulated TNF-a production of four subjects, over time
Results are expressed in pg/ml of TNF-a (stimulated cultures minus unstimulated cultures).
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Table 3.14
PPD-stimulated IL-10 production of four subjects, over time
Results are expressed in pg/ml of IL-10
U - unstimulated; S - stimulated; S -U  - stimulated minus unstimulated
Man Pos 1 Man Pos 2 TB Adu t TB Chilei
Day U S S -U U S S -U U S S -U U S s-u
1 0 116 116 67 879 812 387 844 457 1010 1264 254
2 226 14 0 1134 2244 1110 228 269 41 716 1092 376
3 8 122 114 311 392 81 364 518 154 839 884 45
4 0 66 66 1010 717 0 206 328 122 746 800 54
5 0 402 402 118 0 0 866 504 0 922 870 0
6 142 0 0 929 336 0 378 527 149 386 782 396
7 0 134 134 205 330 125 418 1002 584 958 868 0
Figure 3.14
PPD-stimulated IL-10 production of four subjects, over time
Results are expressed in pg/ml of IL-10 (stimulated cultures minus unstimulated cultures).
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Table 3.15
PHA-stimulated IL-10 production of four subjects, over time
Results are expressed in pg/ml of IL-10
U - unstimulated; S - stimulated; S -U  - stimulated minus unstimulated
Man Pos 1 Man Pos 2 TB AdiLilt TE Child
Day u S S -U U S S -U U S S -U U S S-U
1 0 1435 1435 1633 935 0 420 269 0 1187 2849 1662
2 462 4984 4522 349 3217 2868 31 106 75 966 2968 2002
3 0 6661 6661 1502 3354 1852 583 695 112 1769 1673 0
4 603 5631 5028 318 4015 3697 119 739 620 1633 1249 0
5 0 5200 5200 1122 2762 1640 370 370 0 944 978 34
Figure 3.15
PHA-stimulated IL-10 production of four subjects, over time
Results are expressed in pg/ml of IL-10 (stimulated cultures minus unstimulated cultures).
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Table 3.16
PPD-stimulated IL-4 production of four subjects, over time
Results are expressed in pg/ml of IL-4
U - unstimulated; S - stimulated; S -U  - stimulated minus unstimulated
Mein Pos 1 Man Pos 2 T B Adult TB Child
Day U S S -U U S S -U u S s -u u S S -U
1 0 0 0 8 24 16 0 0 0 57 29 0
2 0 0 0 18 13 0 0 0 0 49 53 4
3 0 0 0 15 28 13 0 0 0 55 42 0
4 0 7 7 11 4 0 0 0 0 36 49 13
5 3 0 0 7 20 13 0 0 0 37 28 0
6 0 5 5 21 12 0 0 0 0 30 67 37
7 11 0 0 14 32 18 0 0 0 48 36 0
Figure 3.16
PPD-stimulated IL-4 production of four subjects, over time
Results are expressed in pg/ml of IL-4 (stimulated cultures minus unstimulated cultures). 
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Table 3.17
PHA-stimulated IL-4 production of four subjects, over time
Results are expressed in pg/ml of IL-4
U - unstimulated; S - stimulated; S -U  - stimulated minus unstimulated
Mein Pos 1 Man Pos 2 TB AdiLilt TB Child
Day U S S- U U S S- U U s s - u u S S-U
1 2 27 25 36 28 0 0 0 0 36 71 35
2 1 67 66 30 86 56 0 0 0 54 44 0
3 0 238 238 37 42 5 0 0 0 38 64 26
4 32 35 3 29 70 41 0 0 0 46 37 0
5 0 42 42 48 33 0 0 0 0 44 60 16
Figure 3.17
PHA-stimulated IL-4 production of four subjects, over time
Results are expressed in pg/ml of IL-4 (stimulated cultures minus unstimulated cultures).
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After examination of all the time courses, it was decided to use the harvesting time points as 
summarised in Table 3.18.
Table 3.18
Harvesting time points of supernatant fluid for cytokine assays
Cytokine PHA PPD
IFN-y Day 4 Day 7
IL-2 Day 3 Day 3
IL-12 Day 4 Day 7
IL-10 Day 3 Day 7
TNF-a Day 3 Day 7
TGF-p Day 4 Day 7
3.1.5 Discussion
3.1.5.1 Reasons for using RPMI as culture medium
Proliferative responses using RPMI and KSLMS were comparable and it was decided that 
RPMI would be used as the culture medium for the present study. The main reason for this 
was that it is more commonly used by other investigators, which would allow the results 
found in this study to be compared more readily to those found in the literature.
3.1.5.2 Effect of the freeze/thaw process on proliferative responses
The freeze/thaw process did not appear to have a dramatic effect on proliferation responses. It 
was therefore decided to include this procedure in the method as it allowed many samples to 
be frozen, before being thawed and transported to the Microbiology laboratory for bulk 
harvesting. This modification proved to be a practical solution to the problem of the location 
of the harvester.
3.1.5.3 Optimal harvesting time points of SNF for cytokine analysis
The majority of investigators have traditionally used isolated PBMC for in-vitro analysis of 
proliferative and cytokine responses. It is therefore not always possible to compare optimum 
harvesting time points obtained in this study with those found in the literature. Furthermore, 
since some of the time courses were so variable among the four subjects, it was not always
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possible to distinguish a clear optimum harvesting time point. Extreme person-to-person 
variation in cytokine production is well known. When this was the case, decisions on choices 
of harvesting times were based on whether the stimulant was a mitogen (PHA) or a specific 
antigen (PPD). Earlier time points (day 3 or day 4) were chosen for PHA stimulation, as the 
immune system does not require time for antigenic processing and presentation, whereas PPD 
does. Day 7 was therefore chosen as harvesting time point for PPD stimulation.
Although some of the cytokine time courses exhibit extreme variability, person-to-person 
variation as well as age-related differences is well recognised. The decision to harvest at one 
particular time point is perhaps an oversimplification, but is based on practicalities such as 
labour, time, blood-taking, cost, comparison, etc.
IFN-y
Day 4 and day 7 were chosen as harvesting time points for IFN-y analysis from PHA- and 
PPD-stimulated cultures respectively. The choice of optimum harvesting time points was 
reasonably simple as the all the time courses concurred (except for PHA-induced IFN-y of the 
child), indicating these to be the optimum time points. PPD- and PHA-stimulated IFN-y 
production in the child was decreased compared to that of the adults. It is well documented 
that IFN-y production in neonates and young children is reduced compared to that of adults 
(Holt et al., 1995; Elsasser-Beile et al., 1995; reviewed by Smith et al., 1997).
These harvesting time points were in agreement with Kluter et al., (1995) and Elsasser-Beile 
et al., (1995), who also chose day 4 as the harvesting time point for PHA-stimulated cultures. 
The kinetics of PPD-induced IFNy production compared well with those found by Elsasser- 
Beile et al (1991).
IL-2
It was decided to harvest supernatant fluid for IL-2 analysis from both PHA- and PPD- 
stimulated cultures on day 3. In general, this time point appeared to be optimal for PHA- 
induced IL-2, as can be seen by the mean concentration on that day. This is in agreement with 
a report by Elsasser-Beile et al., (1991) who found optimal PHA-induced IL-2 secretion at 
between day 2 and day 3. Elliot et al., (1999), however, harvested PPD-stimulated IL-2 on 
day 1. It is important to measure IL-2 levels at a reasonably early time point to avoid the
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problem of receptor-mediated consumption. Therefore, day 3 was chosen for harvesting PPD- 
stimulated IL-2.
TGF-P
Day 4 and day 7 were chosen as harvesting time points for TGF-P analysis from PHA- and 
PPD-stimulated cultures respectively. The time courses for the four individuals were 
extremely variable and no clear optimum harvesting time point for either stimulant could be 
distinguished. The adult with TB produced the highest levels of PPD-induced TGF-p. TB 
patients have previously been shown to produce higher levels of TGF-P when compared to 
healthy Mantoux positive controls. An early time point, day 4, for PHA-stimulated cultures 
was chosen, as this stimulant is a mitogen which does not require time for antigen processing 
and presentation. A later time point, day 7, was chosen for PPD-stimulated cultures to allow 
sufficient time for antigen processing and presentation.
Background counts from unstimulated cultures were high in all individuals throughout both 
time courses. This phenomenon has previously been documented by Hirsch et al., (1996). In 
this study, a possible explanation could be that individuals from the Ravensmead/Uitsig 
community are continually exposed to M.tuberculosis and other environmental factors (for 
example, stress), which could result in their cells being primed, or activated in-vivo. When 
these cells are then put into culture, monocytes (MO) could spontaneously release TGF- 
p. This is possibly why the adult subjects from the Ravensmead/Uitsig community (Man pos 
2 and adult TB subject), produce more background than the adult who is not (Man pos 1).
IL-12
Day 4 and day 7 were also chosen as harvesting time points for IL-12 analysis from PHA- 
and PPD-stimulated cultures respectively. Day 4 was chosen for PHA-stimulated cultures as 
all individuals showed good IL-12 responses at that time point. Day 7 was chosen for PPD- 
stimulated cultures as IL-12 levels were well maintained throughout the 7-day period. It is 
interesting to note the child’s capacity to produce IL-12, (which is an important promoter of 
IFN-y production), is low compared to that of the adults. This could also be an explanation 
for the low levels of IFN-y produced by the child. Quantitation of differences in IL-12 
production between children and adults is a controversial subject.
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Except for Man Pos 1, background counts in unstimulated cultures were high. IL-12 is also 
produced by MO/MA and its presence in this study could be due to the same reasons as 
discussed for TGF-p. The fact that Man pos 1 had no background compared to the individuals 
from the Ravensmead/Uitsig communities lends support to this hypothesis.
TNF-a
Day 3 and day 7 were chosen as harvesting time points for TNF-a from PHA- and PPD- 
stimulated cultures respectively. Except for the child, day 3 showed high levels levels of 
TNF-a for all subjects. Van Crevel et al., (1999) also found a continual increase of TNF-a up 
to day 3. TNF-a appears to contribute to some of the pathology seen in advanced TB in adult 
patients (Filley et al., 1992; Tramontana et al., 1995). This pathology includes fever and 
wasting. Children however, mostly have the lymph node involvement and not much 
pathology. It is interesting to note that PPD-stimulated TNF-a in the child was very low 
compared to that of the other adults. The time course of PPD-stimulated cultures for the four 
individuals was variable and no clear optimal harvesting time point could be distinguished. 
Day 7 was chosen to allow sufficient time for antigen processing and presentation. Van 
Crevel et al., (1999) harvested PHA- and PPD-stimulated cultures for TNF-a on day 3 while 
Elsasser-Beile et al., (1995) harvested their PHA-stimulated cultures for TNF- a  on day 4.
IL-10
Day 3 and day 7 were chosen as harvesting time points for IL-10 analysis from PHA- and 
PPD-stimulated cultures respectively. The trend for both PHA- and PPD-stimulated time 
courses was variable, therefore an earlier (day 3 for PHA) and later (day 7 for PPD) time 
point, was chosen.
Background counts in unstimulated cultures were generally high for both time courses. IL- 
10 is also produced by MO/MA and its presence in this study could be due to the same 
reasons as discussed for TGF-p. Once again, the fact that Man pos 1 had less background, in 
general, than the individuals from the Ravensmead/Uitsig communities also lends support to 
this hypothesis.
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IL-4 levels in PHA- and PPD-stimulated cultures were extremely low in all individuals, 
except for one Mantoux-positive individual, who showed an increased level of IL-4 
production on day 3, following PHA stimulation. It was therefore decided to exclude the 
measurement of IL-4 in this study. Low IL-4 levels have also previously been documented in 
the literature (Petrovsky et al., 1995).
Technical problems with TGF-P and IL-12
During the initial “before therapy” study, it was discovered that the unstimulated background 
values for these cytokines in the group of study subjects recruited from the end of March until 
June 1999 had significantly higher values compared to the previously recruited patients. This 
phenomenon appeared to persist and was present in the follow up “after therapy” study as 
well. No differences could be found in any of the other cytokines and no changes in 
laboratory protocols or reagents had been made. Various measures were taken to investigate a 
possible source of contamination leading to the non-specific production of these cytokines. 
These included the checking of incubators, distilled water systems and laminar flow hoods 
for sources of contamination, changing to commercially-made RPMI as well as reinforcement 
of measures to prevent contamination. The possibility of LPS contamination was excluded by 
measuring the levels of TNF-a and IFN-y in a large subgroup of unstimulated samples at 
various time points (before and after the discovery of the high background levels as well in 
the “after therapy” study). These values were all below detection levels of the assays (15 
pg/ml). Unfortunately, no satisfying reason was found for the high backgrounds in these 
cytokines and it was thus decided to exclude the TGF-P and IL-12 values for all study 
subjects from both the “before” and “after therapy” studies.
3.2 Optimization of the Duoset ELISA system
3.2.1 Background
In our laboratory we previously used prepackaged ELISA kits for the measurement of IFN-y, 
IL-2p40, TGF-p, IL-12p40, TNF-a, IL-10 and IL-4. Each kit contained a matched, fully 
optimized set of reagents as well as buffers and a coated plate. These kits were ready for use 
and did not require any development or optimization. However, the kits proved to be very 
costly as only forty samples (in duplicate) could be analysed from one kit. We therefore 
decided to convert to a Douset ELISA system which allowed analysis of 480 samples. This
IL-4
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system contained the basic components required to develop an immunoassay and included a 
capture antibody, a mass calibrated standard, a biotinylated secondary antibody, streptavidin 
horseradish peroxidase and a generic protocol to aid in the development of an optimized 
protocol.
3.2.2 Determination of optimal concentrations of the capture and secondary antibodies
There are many parameters which influence the results obtained in an ELISA. These include 
component quality, antibody concentrations, incubation times and temperatures, detection 
reagent quality and concentration and substrate type and quality. It was decided to commence 
the optimization procedure by determining the optimal concentrations of the capture and 
secondary antibodies. This was achieved by using the ELISA protocol (Section 2.3.6) to 
titrate the capture antibody against the secondary antibody. Although the basic ELISA 
protocol was followed, there were some modifications. These included dividing the 96-well 
plate into 2 equal components and titrating the capture antibody down the plate and the 
secondary antibody across the plate, in an identical fashion on both halves of the plate (see 
Figure 3.18). Furthermore, on one half of the plate, a constant concentration of sample 
(usually the highest concentration of the standard) was used. On the second half of the plate, 
no antigen was used. Initial experiments produced optical densities that were too low, but 
after increasing the incubation time of the secondary antibody and the substrate, the optical 
densities improved. After the ELISA was completed and the optical densities read, the 
concentrations which gave the best signal to noise ratio were chosen. The left side of the 
plate, which contained antigen, gave a “signal” resulting from each of the many antibody pair 
concentrations. The right side of the plate, with no antigen, gave the “noise” or the 
background value that could be expected for each of the antibody concentrations. The signal 
that produced the highest signal to noise ratio and which still gave an acceptable background 
(<0.3 optical density units), was chosen. Table 3.19 shows a typical example of the optical 
density results obtained when a capture antibody was titrated against a secondary antibody in 
the ELISA protocol.
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Figure 3.18 Plate layout for the titration of the capture and secondary antibody
Capture
Antibody
Concentration
Table 3.19
Typical example of ELISA results obtained when an IFN-y capture antibody was 
titrated against an IFN-y secondary antibody using the ELISA protocol.
Results are expressed in optical density units
Secondary Antibody (fj,g/ml)
5 2.5 1.25 0.62 0.31 0.15
Secondary Antibody (^g/ml)
5 2.5 1.25 0.62 0.31 0.15
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The highest signal to noise ratio was obtained from the concentrations in C3 and C9.
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Table 3.20 shows the concentrations of the capture and secondary antibodies that gave the 
highest signal to noise ratio for each of the cytokines. These concentrations were thus used in 
all subsequent ELISAs.
Table 3.20
Capture and secondary antibody concentrations giving the highest signal to noise ratio 
for each of the cytokines.
Cytokine Capture Antibody Secondary Antibody
IFN-y l|ig/ml 0.625fig/ml
IL-2 2.5j^g/ml 1.25|ag/ml
TGF-p 2|j.g/ml 300ng/ml
IL-12 2(j.g/ml 300ng/ml
TNF-a 2.0 jag/ml 0.25}o,g/ml
IL-10 2^g/ml 250|ag/ml
IL-4 2.0(ig/ml 1.0(j.g/ml
3.2.3 Discussion
Although the antibodies in the Douset kits came with the a range of manufacturer’s 
recommended concentrations, titrations of capture and secondary antibodies had to be 
performed in order to determine the optimal concentration. Results obtained from the titration 
experiments showed that the optimal concentrations fell within the recommended range and 
these were thus used for all subsequent ELISAs. Therefore, although these Duoset kits 
required initial optimization, they proved to be more economical than the prepackaged kits, 
which cost approximately R100 per sample as opposed to the Duoset kit, which cost 
approximately R8.75 per sample.
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IMMUNE RESPONSES OF PATIENTS (WITH A PAST HISTORY OF
69
TB) AND HEALTHY SUBJECTS OF DIFFERENT AGES 
4.1 Study population
Of the 99 subjects (TB patients and Healthy Mantoux positive individuals) studied in the 
initial “before therapy” study, 68 subjects could be followed up and re-studied in this “after 
therapy” study (approximately 1 year after initial investigations). Follow-up of 31 individuals 
was not possible for the following reasons: subjects moved out of the area or were 
untraceable (n = 21), therapy non-compliance (n = 6), development of TB disease in a 
Mantoux positive control (n = 1), received prophylactic therapy (n = 1), refusal to partake in 
study (n = 1) and unsuccessful blood sampling from 1 subject. The subjects who were 
successfully followed up in this study comprised TB patients, who had completed TB therapy 
(n = 27) and healthy Mantoux positive control subjects (n = 41). All adolescent and adult 
patients (n =12) had sputum samples re-tested for presence of M. tuberculosis by ZN staining 
after completion of TB therapy, all of which were negative.
Because of the age-related risk of infection as well as the clinical spectrum of disease, the 
study population was stratified into 2 age groups (<12 years old and > 12 years old). The 
patients with a history of TB (successfully treated TB patients) were classified according to 
their clinical status at diagnosis, either primary TB (<12 years old; n = 15) or postprimary TB 
(>12 years old; n = 12). Table 4.1 shows the number of successfully treated TB patients and 
healthy Mantoux positive control subjects recruited in each age group as well as the 
male/female distribution. Table 4.2 shows the median (interquartile ranges) ages in years for 
each of the age groups. Table 4.3 shows the median (interquartile ranges) Mantoux sizes in 
millimetres (mm) for each of the age groups, which was performed at the initial “before 
therapy” study. The Mantoux test was not repeated in the “after therapy” study.
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Table 4.1
Number and gender of patients with a history of TB and healthy controls per age group
Age Patients Controls Total
Sex (M/F) Sex (M/F) Sex (M/F)
<12 yrs 15 22 37
( 8/ 7 ) (11/11) (19/18)
>12 years 12 19 31
(5/7) (6/13) (11/20)
Total 27 41 68
Sex (M/F) (13/14) (17/24) (30/38)
M = male; F = female
Table 4.2
Median (interquartile ranges) ages in years for patients with a history of TB and
healthy controls
Age n Patients n Controls
<12 years 15 4.1 22 6.2
(2.6-9.5) (4.0-9.4)
>12 years 12 19.2 19 17.1
(15.5-28.4) (13.8-37.0)
Table 4.3
Median (interquartile ranges) of Mantoux sizes in millimetres (mm) for each of the age 
groups.
Age n Patients n Controls
<12 years 14 16.6 22 18.4
(0.00-20.2) (16.2-20.4)
>12 years 5 20.0 19 18.5
(19.0-21.0) (15.7-28.0)
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4.2 Lymphocyte proliferation studies
4.2.1 Proliferation after PHA stimulation
Day 4 PHA-stimulated lymphocyte proliferative responses from diluted whole blood from 
TB patients (with a history of TB) and healthy Mantoux positive controls according to age 
group. Data are represented as box plots showing the median and extending to the 25th and 
75th percentiles. The lines extending from the box extend to upper and lower adjacent values.
100000
< 12yrs
Age group
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Table 4.4
Median (interquartile range: IQ) proliferative responses (cpm) of whole blood stimulated 
with PHA (10^g/ml) (after subtraction of values from unstimulated cultures) for patients with 
with a history of TB and their age-related healthy Mantoux positive controls (<12 yrs or >12 
yrs)
TB status Patients Controls p-value1
Age group 
(years)
n Median
(10)
n Median
(IQ)
<12 years 8 37783
(30495-47897)
19 44612
(26607-60978)
.418
>12 years 8 51700
(36160-82881)
14 32869
(26816-49879)
.029
P-value2 .065 .321
p-value1: Patients <12 years compared to controls <12 years and patients > 12 years 
compared to controls >12 years (Mann-Whitney U test) 
p-value2: Patients <12 years compared to patients >12 years and controls <12 years 
compared to controls >12 years (Mann-Whitney U test)
PHA-stimulated proliferation (cpm) did not correlate in any way with age (yrs). Patients 
>12yrs differed significantly from controls >12yrs (p = .029) with enhanced proliferation 
observed. No other significant differences in PHA-induced proliferative responses were 
found between any of the groups.
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4.2.2 Proliferation after PPD stimulation
Day 7 PPD-stimulated lymphocyte proliferative responses from diluted whole blood from TB 
patients (with a history of TB) and healthy Mantoux positive controls according to age group. 
Data are represented as box plots showing the median and extending to the 25th and 75th 
percentiles. The lines extending from the box extend to upper and lower adjacent values.
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Table 4.5
Median (interquartile range: IQ) proliferative responses (cpm) of whole blood stimulated 
with PPD (3.3|ig/ml) (after subtraction of values from unstimulated cultures) for patients with 
with a history of TB and their age-related healthy Mantoux positive controls (<12 yrs or >12 
yrs)
TB status Patients Controls p-value1
Age group
(years)
n Median
(IQ)
n Median
(IQ)
<12 years 8 26981
(5001-31420)
19 16257
(10058-24460)
.515
>12 years 8 33973
(20668-49111)
14 19351
(10893-23372)
.020
P-value2 .161 .900
p-value1: Patients <12 years compared to controls <12 years and patients > 12 years 
compared to controls >12years (Mann-Whitney U test) 
p-value2: Patients <12 years compared to patients >12 years and controls <12 years 
compared to controls >12 years (Mann-Whitney U test)
PPD-stimulated proliferation (cpm) did not correlate in any way with age. Patients >12yrs 
differed significantly from controls >12yrs (p = .020) with enhanced proliferation observed. 
No other significant differences in PPD-induced proliferative responses were found between 
any of the groups.
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4.3 Cytokine studies
4.3.1 IFN-y production
4.3.1.1 IFN-y production after PHA stimulation
Day 4 PHA-stimulated IFN-y production from diluted whole blood from TB patients (with a 
history of TB) and healthy Mantoux positive controls according to age group. Data are 
represented as box plots showing the median and extending to the 25th and 75th percentiles. 
The lines extending from the box extend to upper and lower adjacent values.
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Table 4.6
Median (interquartile range: IQ) of IFN-y in pg/ml after stimulation of whole blood with 
PHA (lO^g/ml) for patients with a history of TB and their age-related healthy Mantoux 
positive controls (<12 yrs or >12 yrs)
TB status Patients Controls p-value
Age group 
(years)
n Median
(IQ)
n Median
(IQ)
<12 years 15 19937
(13760-32102)
22 27114
(16488-37942)
0.417
>12 years 12 68351
(36537-91963)
19 40441
(25939-75349)
0.205
P-value2 .001 .044
p-value1: Patients <12 years compared to controls <12 years and patients > 12 years 
compared to controls >12 years (Mann-Whitney U test) 
p-value2: Patients <12 years compared to patients >12 years and controls <12 years 
compared to controls >12years (Mann-Whitney U test)
Age (yrs) correlated significantly with PHA-induced IFN-y (pg/ml) within the whole study 
group (n = 68; r = .603, /?<.001) as well as for all patients (n = 27; r = .740, p  <.001) and all 
controls (n = 41; r = .466, p  = .002). Patients, as well as controls <12 years, produced 
significantly less IFN-y than their older counterparts (p = .001 and p  = .044).
There was no significant correlation between values for PHA-stimulated IFN-y and values for 
PHA-induced proliferation in any of the groups.
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4.3.1.2 IFN-y production after PPD stimulation
Day 7 PPD-stimulated IFN-y production from diluted whole blood from TB patients (with a 
history of TB) and healthy Mantoux positive controls according to age group. Data are 
represented as box plots showing the median and extending to the 25th and 75th percentiles. 
The lines extending from the box extend to upper and lower adjacent values.
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Table 4.7
Median (interquartile range: IQ) of IFN-y in pg/ml after stimulation of whole blood with PPD 
(3.3|ig/ml) for patients with a history of TB and their age-related healthy Mantoux positive 
controls (<12 yrs or >12 yrs)
TB status Patients Controls p-value1
Age group 
(years)
n Median
(IQ)
n Median
(10)
<12 years 15 9396
(3792-16779)
22 21239
(9902-30962)
0.024
>12 years 12 15364
(7566-20549)
19 19078
(11920-31038)
0.141
P-value2 .256 .896
p-value1: Patients <12 years compared to controls <12 years and patients > 12 years 
compared to controls >12 years (Mann-Whitney U test) 
p-value2: Patients <12 years compared to patients >12 years and controls <12 years 
compared to controls >12 years (Mann-Whitney U test)
Age (yrs) did not correlate with PPD-induced IFN-y production (pg/ml) for any of the groups. 
Patients <12 yrs produced significantly less IFN-y than controls <12 yrs (p = 0.024).
There was no significant correlation between values for PPD-stimulated IFN-y and values for 
PPD-induced proliferation when all samples were analysed (n = 49) or when values for all 
patients (<12yrs and >12yrs; n = 16) were analysed. When values all for controls (<12yrs and 
>12yrs; n = 33) were analysed, a positive and significant correlation with proliferation (r = 
.410,/? = .018) was demonstrated.
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4.3.2.1 IL-2 production after PHA stimulation
Day 3 PHA-stimulated IL-2 production from diluted whole blood from TB patients (with a 
history of TB) and healthy Mantoux positive controls according to age group. Data are 
represented as box plots showing the median and extending to the 25th and 75th percentiles. 
The lines extending from the box extend to upper and lower adjacent values.
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Table 4.8
Median (interquartile range: IQ) of IL-2 in pg/ml after stimulation of whole blood with PHA 
(lOfig/ml) for patients with a history of TB and their age-related healthy Mantoux positive 
controls (<12 yrs or >12 yrs)
TB status Patients Controls p-value1
Age group n Median n Median
(years) (IQ) (IQ)
<12 years 15 86 22 106 .939
(61-305) (49-282)
>12 years 12 276 19 174 .287
(157-513) (40-436)
P-value2 .103 .676
p-value1: Patients <12 years compared to controls <12 years and patients > 12 years 
compared to controls >12 years (Mann-Whitney U test)
■y
p-value : Patients <12 years compared to patients >12 years and controls <12 years 
compared to controls >12years (Mann-Whitney U test)
Age (yrs) did not correlate with PHA-induced IL-2 production (pg/ml) in any of the study 
groups. Nor were there any other significant differences between any of the study groups.
When all samples were analysed (n = 68), PHA-induced IL-2 correlated positively with 
PHA-induced proliferation (r = .444, p  = .001) and IFN-y (r =. 518, p  <.001). When values 
for all controls were analysed (n = 41), all these correlations remained significant 
(proliferation: r = .529, p  = .002; IFN-y: r = .464, p  = .002), but only for IFN-y (r = .579, p  = 
.002) when values for all patients were analysed (n = 27).
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4.3.2.2 IL-2 production after PPD stimulation
Day 3 PPD-stimulated IL-2 production from diluted whole blood from TB patients (with a 
history of TB) and healthy Mantoux positive controls according to age group. Data are 
represented as box plots showing the median and extending to the 25th and 75th percentiles. 
The lines extending from the box extend to upper and lower adjacent values.
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Table 4.9
Median (interquartile range: IQ) of IL-2 in pg/ml after stimulation of whole blood with PPD 
(3.3pg/ml) for patients with a history of TB and their age-related healthy Mantoux positive 
controls (<12 yrs or >12 yrs)
TB status Patients Controls p-value1
Age group n Median n Median
(years) (10) (10)
<12 years 15 “ 111 22 104 .915
(21-152) (45-162)
>12 years 12 49 19 87 .287
(30-120) (30-176)
P-value2 .399 .896
p-value1: Patients <12 years compared to controls <12 years and patients > 12 years 
compared to controls >12years (Mann-Whitney U test) 
p-value2: Patients <12 years compared to patients >12 years and controls <12 years 
compared to controls >12 years (Mann-Whitney U test)
Age (yrs) demonstrated a negative correlation with PPD-induced IL-2 (pg/ml), but this did 
not reach significance when the whole study group was analysed. This non-significant 
negative correlation was maintained for patients as well as controls.
PPD-induced IL-2 correlated positively with proliferation (r = .561, p  <.001) and IFN-y (r = 
.505, p  <.001) after PPD stimulation, when all subjects were analysed (n = 68). This positive 
correlation was maintained when values for all controls (n = 41) were analysed (proliferation: 
r = .737, p  <.001; IFN-y: r = .591, p  <.001) as well as when values for all patients (n = 27) 
were analysed (proliferation: r = .509,p =  .044; IFN-y: r = .388, p  = .046).
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4.3.3.1 TNF-a production after PHA stimulation
Day 3 PHA-stimulated TNF-a production from diluted whole blood from TB patients (with a 
history of TB) and healthy Mantoux positive controls according to age group. Data are 
represented as box plots showing the median and extending to the 25th and 75th percentiles. 
The lines extending from the box extend to upper and lower adjacent values.
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Table 4.10
Median (interquartile range: IQ) of TNF-a in pg/ml after stimulation of whole blood with 
PHA (10fj.g/ml) for patients with a history of TB and their age-related healthy Mantoux 
positive controls (<12 yrs or >12 yrs)
TB status Patients Controls p-value1
Age group 
(years)
N Median
(10)
n Median
(IQ)
<12 years 15 172
(141-433)
22 142
(94-353)
.319
>12 years 12 573
(286-961)
19 427
(167-684)
.236
P-value2 .010 .032
p-value : Patients <12 years compared to controls <12 years and patients > 12 years 
compared to controls >12 years (Mann-Whitney U test) 
p-value2: Patients <12 years compared to patients >12 years and controls <12 years 
compared to controls >12 years (Mann-Whitney U test)
Age (yrs) correlated significantly with PHA-induced TNF-a (pg/ml) within the whole study 
group (n = 68; r = .518,/? <.001) as well as for all patients (n = 21\r=  .571,/? = .002) and all 
controls (n = 41; r = .483, p  = .001). Patients and controls (<12yrs) produced significantly 
less than their older (>12yrs) counterparts (p = .010 andp  = .032 respectively).
PHA-induced TNF-a correlated positively with proliferation (r = .295, p  = .040), IFN-y (r = 
.679, p  <.001) and IL-2 (r = .599, p  <.001) when all samples were analysed (n = 68). When 
values for all patients were analysed (n = 27) the positive correlation was not maintained for 
proliferation, but was maintained for IFN-y (r = 681, p  <.001) and IL-2 (r = .692, p  <.001). 
When values for all controls were analysed (n = 41) the positive correlation was also lost for 
proliferation, and was also maintained for IFN-y (r = .706, p  <.001) and IL-2 (r = .547, p  
<.001). PHA-induced TNF-a also demonstrated a positive and significant correlation with 
PHA-induced IL-10, but only in controls (r = .369, p -  .018), and not patients.
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4.3.3.2 TNF-a production after PPD stimulation
Day 7 PPD-stimulated TNF-a production from diluted whole blood from TB patients (with a 
history of TB) and healthy Mantoux positive controls according to age group. Data are 
represented as box plots showing the median and extending to the 25th and 75th percentiles. 
The lines extending from the box extend to upper and lower adjacent values.
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Table 4.11
Median (interquartile range: IQ) of TNF-a in pg/ml after stimulation of whole blood with 
PPD (3.3|j.g/ml) for patients with a history of TB and their age-related healthy Mantoux 
positive controls (<12 yrs or >12 yrs)
TB status Patients Controls p-x alue
Age group n Median n Median
(years) (10) (IQ)
<12 years 15 60 22 56 .939
(31-90) (33-80)
>12 years 12 55 19 43 .306
(27-74) (29-55)
p-value2 .755 .191
p-value1: Patients <12 years compared to controls <12 years and patients > 12 years 
compared to controls >12 years (Mann-Whitney U test) 
p-value2: Patients <12 years compared to patients >12 years and controls <12 years 
compared to controls >12 years (Mann-Whitney U test)
Age did not correlate with PPD-induced TNF-a production in any way.
PPD-induced TNF-a showed a weak positive correlation with PPD-induced IFN-y (r = .288, 
p  = .017) when all samples were analysed (n = 68). When values for all patients were 
analysed (n = 27), the positive correlation was maintained (r = .499, p  = .008) but was not 
maintained when values for all controls were analysed (n = 41).
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4.3.4.1 IL-10 production after PHA stimulation
Day 3 PHA-stimulated IL-10 production from diluted whole blood from TB patients (with a 
history of TB) and healthy Mantoux positive controls according to age group. Data are 
represented as box plots showing the median and extending to the 25th and 75th percentiles. 
The lines extending from the box extend to upper and lower adjacent values.
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Table 4.12
Median (interquartile range: IQ) of IL-10 in pg/ml after stimulation of whole blood with PHA 
(lOpg/ml) (after subtraction of values from unstimulated cultures) for patients with a history 
of TB and their age-related healthy Mantoux positive controls (<12 yrs or >12 yrs)
TB status Patients Controls p-value'
Age group 
(years)
n Median
(IQ)
n Median
(IQ)
<12 years 15 159
(92-488)
22 352
(105-681)
.614
>12 years 12 227
(72-648)
19 631
(298-803)
.043
P-value2 .905 .030
p-value1: Patients <12 years compared to controls <12 years and patients > 12 years 
compared to controls >12 years (Mann-Whitney U test) 
p-value2: Patients <12 years compared to patients >12 years and controls <12 years 
compared to controls >12 years (Mann-Whitney U test)
Age (yrs) correlated significantly with PHA-induced IL-10 (pg/ml) within the whole study 
group (n = 68; r = .354,p  = .003) as well as for all controls (n = 41; r = .549,p  <.001) but not 
for all patients (n = 27). Controls <12 yrs old produced significantly less IL-10 than controls 
>12 yrs old (p = .030). In addition, patients >12yrs old produced significantly less IL-10 than 
controls >12yrs old (p = .043)
PHA-stimulated IL-10 correlated positively with PHA-stimulated IFN-y (r = .414, p  <.001) 
and IL-2 (r = .308, p  = .011) when all samples were analysed (n = 68). When values for all 
controls were analysed (n = 41), correlations remained significant for IFN-y (r = .552, p  
<.001) and IL-2 (r = .451, p  =.003). When values for all patients were analysed (n = 27), 
these significant correlations were lost. PHA-induced IL-10 also correlated positively with 
TNF-a (r = .369, p  = .018), but only when values for controls were analysed (n = 41).
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4.3.4.2 IL-10 production after PPD stimulation
Day 7 PPD-stimulated IL-10 production from diluted whole blood from TB patients (with a 
history of TB) and healthy Mantoux positive controls according to age group. Data are 
represented as box plots showing the median and extending to the 25th and 75th percentiles. 
The lines extending from the box extend to upper and lower adjacent values.
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Table 4.13
Median (interquartile range: IQ) of IL-10 in pg/ml after stimulation of whole blood with PPD 
(3.3|ig/ml) (after subtraction of values from unstimulated cultures) for patients with a history 
of TB and their age-related healthy Mantoux positive controls (<12 yrs or >12 yrs)
TB status Patients Controls p-value1
Age group n Median n Median
(years) (IQ) (IQ)
<12 years 15 28 22 11 .225
(9-64) (4-49)
>12 years 12 10 19 15 .412
(6-15) (1-25)
P-value2 .114 .565
p-value1: Patients <12 years compared to controls <12 years and patients > 12 years 
compared to controls >12 years (Mann-Whitney U test) 
p-value2: Patients <12 years compared to patients >12 years and controls <12 years 
compared to controls >12years (Mann-Whitney U test)
Age (yrs) showed a negative correlation with PPD-induced IL-10 (pg/ml) for all samples (n = 
68). This correlation did not reach significance within the whole study group, but when 
patients and controls were analysed separately, the negative correlation demonstrated a weak 
negative significance for patients (n = 27; r = -.415,/? = .032). Values were extremely low for 
all samples.
PPD-induced IL-10 did not correlate in any way with PPD-induced proliferation or any of the 
PPD-induced cytokines.
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4.4.1 Lymphocyte proliferation assays
This assay measures [3H] thymidine uptake into the DNA of dividing cells and is a 
commonly used method for assessing cellular proliferation in response to a particular mitogen 
or a specific antigen. Mitogenic stimulation results in non-specific activation of multiple T 
cells and is generally used to assess maximal proliferative capacity not necessarily related to 
antigen exposure while specific antigenic stimulation will reflect prior exposure and 
sensitisation of the subject to that particular antigen.
Most studies in the literature have found that circulating neonatal T cells and adult T cells 
have similar proliferative responses to mitogens, bacterial superantigens or alloantigens 
(Clerici et al., 1993; Hayward et al., 1994). Our study was in agreement with this data, as age 
did not correlate in any way with PHA- or PPD-induced proliferative responses. Pollard et 
al., (1999) found no age-related differences in proliferative responses of PBMCs of children 
convalescing from meningococcal disease or controls less than 10 years of age (in response to 
meningococcal antigens), although there was a trend toward higher responses in children over 
10 years of age. Similarly, Smart et al., (2001) found no age-related differences in 
staphylococcal enterotoxin B-stimulated PBMCs from normal healthy children as well as 
atopic children.
The positive correlation between PHA and PPD-induced proliferative responses and IL-2 
supports the fact that this cytokine is a growth factor for T cells and is necessary for T cell 
proliferation.
Cured TB patients older than 12 years proliferated significantly more in response to PHA and 
PPD than their age-matched healthy controls. Enhanced proliferation in cured TB patients 
could possibly be due to an increased number of memory T cells which were still circulating 
in the peripheral blood. This would expand the total T cell pool, which could result in an 
increased proliferative response to PHA and PPD, compared to that of the age-matched 
controls. The PPD-induced proliferative responses demonstrated a significant positive 
correlation with IFN-y (for controls only). The finding that there was no correlation between 
IFN-y and PHA- induced proliferative responses demonstrates that stimulation with different
4.4 Discussion
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antigens can influence lymphocyte proliferation in relation to cytokine production. Ribera et 
al., (1990) report a significant positive correlation between PPD-induced proliferation results 
and IFN-y production in healthy controls, but not TB patients. D’Andrea et al., (1986) also 
report a positive correlation between cytomegalovirus-stimulated proliferation values and 
IFN-y production in healthy cytomegalovirus seropositive adults, while Surcel et al., (1994) 
have previously reported a discordant relationship between lymphocyte proliferation and 
IFN-y, after stimulation with various M.tuberculosis proteins.
PHA-stimulated proliferative responses, but not PPD-stimulated proliferative responses, 
showed a weak positive correlation with TNF-a for all samples. This finding demonstrates 
that different stimulating agents can elicit quite distinct patterns of cytokine production.
The findings of this study indicate that the proliferation assay appears to correlate with IL-2 
production, however it does not appear to correlate with age and therefore would probably 
not be useful in the assessment of age-related function.
4.4.2 Cytokine studies
4.4.2.1 IFN-y production
As mentioned previously in the introductory chapters, IFN-y is an important cytokine 
involved in host defence from M.tuberculosis. Young children, who are particularly 
susceptible to TB disease, have decreased production of IFN-y (Holt et al., 1995; reviewed by 
Smith et al., 1997). The majority of reports in the literature on IFN-y production in children 
have been performed on newborn and very young children. These reports have shown 
decreased PHA-induced IFN-y production by cord blood lymphocytes compared to adults 
(Wakasugi et al.,1985; Frenkel et al., 1987; Vigano et al., 1999; Perenne-Ansart et al., 1995). 
Elssasser-Beile et al., (1995), using a whole blood assay, also report significantly lower PHA- 
induced IFN-y production in children under 10 years of age, compared to adults. This study is 
in agreement, as it has shown a strong correlation with PHA-induced IFN-y and age. Various 
factors are likely to be involved. Lack of exposure to antigen, as shown by a predominantly 
“naive” T cell phenotype in neonatal peripheral blood (Hassan et al., 1996), is probably a 
crucial factor. Exaggerated cellular sensitivity to the suppressive effect of prostaglandin E,
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produced endogenously in normal amounts, has also been shown to be involved (Wakasuki et 
al., 1985). In their study, Taylor and Bryson (1985), have demonstrated that functionally 
immature macrophages are primarily responsible for the impaired IFN-y response by neonatal 
newborn cells.
The positive correlation with age was lost when PPD was used as a stimulant. Lilic et al., 
(1997) also did not find any significant difference in IFN-y production in healthy children 
(mean age of 9 years) and adults (mean age of 32 years) after specific antigenic stimulation. 
It therefore seems likely that the nature of the antigen determines if there is a relationship 
between age and the amount of cytokine produced.
PPD-induced IFN-y values for controls correlated significantly with proliferation. This has 
previously been reported (Ribera et al., 1990).
The close agreement with limited data from the literature suggests that the data obtained from 
these experiments is reasonably reliable. The findings in this study indicate that the 
production of PHA-induced, but not PPD-induced, IFN-y was age-related and therefore it 
appears that the nature of the antigen determines if there is a relationship between age and the 
amount of cytokine produced.
4.4.2.2 IL-2 production
IL-2 acts as an autocrine and paracrine growth factor of T cells, helping to expand a pool of 
antigen-specific effector cells. It also increases the capacity of effector T cells to produce 
additional cytokines when they are reactivated by antigen (Smith, 1993). The production of 
IL-2 occurs early after T cell activation and this was confirmed by our kinetics experiments, 
which demonstrated maximal production on day 3 for both PHA- and PPD-stimulated 
cultures.
IL-2 production from neonates was found to be greater than or similar to that of adults 
(Clerici et al.,1993; Wilson et al.,1986; Miyawaki et al., 1985; Ehlers et al., 1991 ) or 
significantly decreased compared to adults (Splawski et al., 1991). Lilic et al., (1997) 
demonstrated significantly decreased production of mitogenic- and antigenic-induced IL-2 in 
PBMC of children (n = 10; mean age of 9 years) compared to that of adults (n = 10; mean age
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of 32 years). Elsasser-Beile et al., (1995), using a whole blood system, also found decreased 
amounts of PHA-induced IL-2 in children, aged between 1 and 9 years old (n= 33) compared 
to adults, aged between 20 and 59 years old (n = 67). Our study showed no relationship 
between age and PHA- or PPD-stimulated IL-2 production.
PHA-and PPD-induced IL-2 both correlated positively with proliferation and IFN-y. Lilic et 
al., (1997) also demonstrated a significant positive correlation between IFN-y and IL-2 in 
healthy children, but not adults. This relationship is plausible as both of these cytokines are 
type 1 cytokines.This correlation is consistent with the fact that that IL-2 is required for 
proliferation and generation of cytokine-producing effectors and both cytokines are 
considered to be Thl cytokines.
The findings of this study indicate that the production of IL-2 does not appear to be related to 
age.
4.4.2.3 TNF-a production
TNF-a is important in the formation of granulomas during M.tuberculosis disease, but it also 
has some detrimental effects on the host, such as cachexia and fever when produced in 
excess.
In children, TNF-a production is described as modestly reduced compared to adults (English 
et al., 1988; Seghaye et al., 1998). Elsasser-Beile et al., (1995), using a whole blood system, 
also demonstrated decreased PHA-induced TNF-a production in children less than 10 years 
of age, compared to adults. Our study was in concordance, demonstrating a positive 
correlation between age and PHA-induced TNF-a production. One of the few studies that 
used a specific antigen to induce TNF-a production in healthy children demonstrated that 
TNF-a production, after meningococcal antigen stimulation, was strongly age-dependent in 
control children but not in children after meningococcal infection (Pollard et al., 1999).
PHA- and PPD- induced TNF-a correlated positively with IFN-y. This positive correlation 
could be due to the finding that the production of both of these cytokines was shown to be 
age-dependent after PHA stimulation. PHA-induced, but not PPD- induced TNF-a correlated
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positively with IL-2. This finding once again demonstrates that different stimulating agents 
can elicit quite distinct patterns of cytokine production.
Generally, levels of TNF-a produced by PHA and PPD stimulation were very low in this 
whole blood system. Elsasser-Beile et al., (1995), also using a whole blood system, report 
median PHA-induced TNF-a values to be 340ng/ml and 920ng/ml in children and adults 
respectively. These values are markedly higher than the values found in this study. This 
difference can probably be ascribed to the fact that the final concentration of PHA in their 
study was lOmg/ml as opposed to 10|j.g/ml, in this study.
The findings in this study indicate that the production of TNF-a appears to be age-related 
(after PHA stimulation) and therefore, may be useful in the assessment of immune response 
function at various ages.
4.4.2.4 IL-10 production
IL-10 production in the human response to M.tuberculosis is considered to be anti­
inflammatory as it appears to have a down-regulatory effect on IFN-y and TNF-a production. 
This was demonstrated when recombinant human IL-10 was added to PPD-stimulated 
monocyte cell cultures from PPD skin test positive subjects (Othieno et al., 1999).
Decreased IL-10 production has been reported in cord blood mononuclear cells compared to 
PBMCs from adults (Chheda et al., 1996). Pollard et al., (1999) reported higher values in 
older children compared to younger children, but this difference was not significant. The 
production of IL-10 from chord whole blood cultures was found to be similar to that of adults 
(Seghaye et al., 1999). Other studies on IL-10 production in children with various diseases 
have been reported, but no conclusions on age-relationship have been mentioned. Our study 
found that PHA-stimulated IL-10 correlated positively with age.
PPD-induced IL-10 concentration was generally extremely low. This phenomenon was also 
found when immune responses of these subjects were examined in the “before therapy” 
study, approximately one year earlier. One report of PPD-induced IL-10 in whole blood in 
the literature could be located (Van Crevel et al., 1999). The authors found measurable 
amounts of PHA-induced, but not PPD-induced IL-10, in PPD skin-test positive as well as
Stellenbosch University http://scholar.sun.ac.za/
96
PPD skin-test negative controls. The phenomenon of finding measurable PHA-induced, but 
not PPD-induced IL-10 in whole blood is intriguing and would be interesting to study in 
greater depth. Plasma components such as cortisol (Petrovsky et al., 1994), lipids (Ulevitch 
and Johnston, 1978) or soluble cytokine receptors (Dinarello, 1996) may all influence results.
PHA-induced IL-10 correlated positively with proliferation, IFN-y and IL-2. The relationship 
between IFN-y, IL-2 and IL-10 is plausible as IFN-y and IL-2 are considered to be a Thl 
cytokines, while both Thl and Th2 phenotypes can secrete IL-10 in humans (Zhai et al 1999). 
This correlation perhaps reflects an age-related regulation between these cytokines. The 
production of IL-10 does not seem to have a down-regulatory effect on the production of 
IFN-y in these conditions. A positive correlation was also found between PHA-induced TNF- 
aand  PHA-induced IL-10 in control subjects. This correlation has previously been 
documented by Pollard et al., 1999, who suggest that release of IL-10 is involved in the 
regulation of TNF-a.
The findings of this study indicate that the production of PHA-induced IL-10 appears to be 
age-related.
4.5 Summary
In this section of the study, subjects with a past history of TB (successfully treated TB 
patients) and healthy Mantoux positive controls, of different ages, were investigated for their 
proliferative and cytokine responses to a mitogen (PHA) and a specific mycobacterial antigen 
(PPD).
Age was a significant variable for the following PHA-stimulated cytokines: IFN-y, TNF-a 
and IL-10. Proliferation and IL-2 production after PHA stimulation did not demonstrate any 
relationship with age.
None of the PPD-induced proliferative or cytokine responses demonstrated any correlation 
with age.
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CHAPTER 5
IMMUNE RESPONSES OF TB PATIENTS BEFORE TREATMENT (AT
97
DIAGNOSIS) COMPARED TO IMMUNE RESPONSES AFTER
TREATMENT
5.1 Study population
The study population comprised TB patients (n = 27) and apparently healthy Mantoux 
positive control subjects (n = 41). The TB patients had immune responses studied before 
commencement of TB therapy, at diagnosis, (referred to as the “before therapy” study from 
here on) and again after therapy, approximately 6 months after completion of treatment 
(referred to as the “after therapy” study from here on). None of the healthy controls received 
any treatment during this period and they had their immune responses tested at the same time 
intervals as the TB patients. For ease of reference, the data for healthy controls will therefore 
also be presented as “before therapy” and “after therapy” results, even though they did not 
receive any treatment. This chapter thus reports on the comparison of the results for patients 
and controls at the two time points. Table 5.1 shows the median (interquartile ranges) ages in 
years for patients and controls in the “before and after therapy” study.
Note: The “before therapy” study formed part of another study and was performed by another 
researcher.
Table 5.1
Median (interquartile ranges) ages in years for patients and controls “before therapy”
and “after therapy”
“Before therapy” “After therapy”
n Median n Median
(IQ) (IQ)
pts <12 years 15 3.1 15 4.1
(1.6-7.9) (2.6-9.5)
con <12 years 22 5.2 22 6.2
(3.0-8.4) (4.0-9.4)
pts >12 years 12 18.2 12 19.2
(14.5-27.4) (15.5-28.4)
con >12 years 19 16.1 19 17.1
(12.8-36.0) (13.8-37.0)
Total 68 10.5 68 11.5
(4.3-16.6) (5.3-17.6)
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5.2 Lymphocyte proliferation studies
5.2.1 Proliferation after PHA stimulation
Day 4 PHA-stimulated lymphocyte proliferative responses from diluted whole blood from 
TB patients and healthy Mantoux positive controls according to age group, “ before therapy” 
and “after therapy”. Data are represented as box plots showing the median and extending to 
the 25th and 75th percentiles. The lines extending from the box extend to upper and lower 
adjacent values.
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Table 5.2
Median (interquartile range: IQ) proliferative responses (cpm) of whole blood stimulated 
with PHA (10|ig/ml) (after subtraction of values from unstimulated cultures) for TB patients 
and their age-related healthy Mantoux positive controls (<12 yrs or >12 yrs), “before 
therapy” (at TB diagnosis) and “after therapy” (approximately 1 year later)
“Before therapy “After therapy”
n Median
(IQ) P~ i value
n Median
(IQ)
p - , 
value
p - 2 
value
pts <12 years 8 33535
(23191-54128) .449
8 37783
(30495-47897) .418 .674
con <12 years 19 43785
(23591-80297)
19 44612
(26607-60978) .629
pts >12 years 7 23917
(5261-33325) .010
7 54152
(34780-86918) .038 .063
con >12 years 14 59157
(31718-85799)
14 32869
(26816-49879) .074
Total 48 38154
(23672-75719)
48 40747
(29423-57592) .580
p-value1: Values o f  patients <12 yrs compared to values o f  controls <12 yrs and values o f  
patients >12 yrs compared to values o f controls >12 yrs (Mann-Whitney U test) 
p-value2: Values o f  each group, “before therapy ”, compared to values o f  each group, ” after 
therapy ” (Wilcoxin Ranks test)
PHA-induced proliferative responses of patients >12yrs, which were significantly lower than 
controls >12 yrs “before therapy”, showed a dramatic increase “after therapy”, but the 
difference fell just short of achieving statistical significance. Controls >12yrs had higher 
proliferation values “before therapy”, compared to “after therapy”, but the difference did not 
achieve statistical significance
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5.2.2 Proliferation after PPD stimulation
Day 7 PPD-stimulated lymphocyte proliferative responses from diluted whole blood from TB 
patients and healthy Mantoux positive controls according to age group, “ before therapy” and 
“after therapy”. Data are represented as box plots showing the median and extending to the 
25th and 75th percentiles. The lines extending from the box extend to upper and lower 
adjacent values.
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Table 5.3
Median (interquartile range: IQ) proliferative responses (cpm) of whole blood stimulated 
with PPD (3.3|j.g/ml) (after subtraction of values from unstimulated cultures) for TB patients 
and their age-related healthy Mantoux positive controls (<12 yrs or >12 yrs) “before therapy” 
(at TB diagnosis), and “after therapy” (approximately 1 year later)
“Before therapy “After therapy”
n Median
(IQ) P~ , value
n Median
(IQ)
P- ,
value
P~ 2
value
pts <12 years 7 16587
(5070-26042) .297
7 25833
(3962-28737) .615 1.000
con <12 years 18 30640
(12562-58365)
18 15981
(9400-22492) .025
pts >12 years 7 5370
(3035-16731) .046
7 31788
(18114-51862) .046 .028
con >12 years 14 47293
(5382-84145)
14 19351
(10893-23372) .013
Total 46 19229
(7709-56460)
46 19155
(9573-26834) .042
p-value': Values o f patients <12 yrs compared to values o f  controls <12 yrs and values o f  
patients >12 yrs compared to values o f  controls >12 yrs (Mann-Whitney U test) 
p-value2: Values o f  each group, ” before therapy”, compared to values o f each group, “after 
therapy”(Wilcoxin Ranks test)
PPD-induced proliferative responses for TB patients > 12yrs were again significantly lower 
than controls “before therapy” (p = .046), and also demonstrated an increase “after therapy”, 
but this time the difference was statistically significant (p = .028). Values for controls <12 yrs 
as well as values for controls >12yrs were lower “after therapy” compared to “before 
therapy”, and this time the differences also achieved statistical significance (p = .025 and p  = 
.013 respectively).
When the values of all controls (n = 32) were analysed, PPD-induced proliferation was 
significantly lower “after therapy”, compared to “before therapy” (p =.001). (data not shown 
on table).
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5.3.1 IFN-y production
5.3.1.1 IFN-y production after PHA stimulation
Day 4 PHA-stimulated IFN-y production from diluted whole blood from TB patients and 
healthy Mantoux positive controls according to age group, “ before therapy” and “after 
therapy”. Data are represented as box plots showing the median and extending to the 25th and 
75th percentiles. The lines extending from the box extend to upper and lower adjacent values.
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Table 5.4
Median (interquartile range: IQ) of IFN-y in pg/ml after stimulation of whole blood with 
PHA (lOpg/ml) for TB patients and their age-related healthy Mantoux positive controls (<12 
yrs or >12 yrs) “before therapy” (at TB diagnosis), and “after therapy” (approximately 1 year 
later)
“Before therapy” “After therapy”
n Median
(10)
p - , 
value
n Median
(IQ)
P~ . value
p - 2 
value
pts <12 years 15 2016
(560-40188) .182
15 19937
(13760-32102) .417 .173
con <12 years 22 15176
(4572-36115)
22 27114
(16488-37942) .200
pts >12 years 12 15179
(5624-50375) .027
12 68351
(36537-91963) .205 .060
con >12 years 19 35045
(15450-74518)
19 40441
(25939-75349) .687
Total 68 15502
(4449-56077)
68 31646
(20176-55921) .018
p-value1: Values o f  patients <12 yrs compared to values o f  controls <12 yrs and values o f  
patients >12 yrs compared to values o f  controls >12 yrs (Mann-Whitney U test) 
p-value2: Values o f  each group, “before therapy”, compared to values o f each group, “after 
therapy ” (Wilcoxin Ranks test)
Patients >12 yrs, who produced significantly less IFN-y in response to PHA stimulation 
compared to controls >12 yrs, “before therapy” (p = .027), showed a dramatic increase “after 
therapy”, but the difference fell just short of achieving statistical significance.
When the values of all patients (n = 27) were analysed, PHA-induced IFN-y production was 
significantly higher “after therapy”, compared to “before therapy” (p =.025). (data not shown 
on table).
PHA-induced IFN-y values for all samples “after therapy” were also significantly higher than 
values for all samples “before therapy” (n = 68;p  = .018).
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5.3.1.2 IFN-y production after PPD stimulation
Day 7 PPD-stimulated IFN-y production from diluted whole blood from TB patients and 
healthy Mantoux positive controls according to age group, “ before therapy” and “after 
therapy”. Data are represented as box plots showing the median and extending to the 25th and 
75th percentiles. The lines extending from the box extend to upper and lower adjacent values.
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Table 5.5
Median (interquartile range: IQ) of IFN-y in pg/ml after stimulation of whole blood with PPD 
(3.3jig/ml) for TB patients and their age-related healthy Mantoux positive controls (<12 yrs 
or >12 yrs) “before therapy” (at TB diagnosis), and “after therapy” (approximately 1 year 
later)
“Before therapy” “After therapy”
n Median
(IQ)
P-
value1
n Median
(IQ)
P- ,
value
P- 2
value
pts <12 years 15 8226
(1802-18465) .258
15 9396
(3792-16779) .024 1.000
con <12 years 22 15675
(4477-24291)
22 21239
(9902-30962) .223
pts >12 years 12 8139
(3713-29360) .845
12 15364
(7566-20249) .141 .814
con >12 years 19 11968
(4758-33573)
19 19078
(11920-31038) .445
Total 68 9623
(3935-28460)
68 16741
(8382-24947) .279
p-value1: Values o f  patients <12 yrs compared to values o f  controls <12 yrs and values o f  
patients >12 yrs compared to values o f  controls >12 yrs (Mann-Whitney U test) 
p-value2: Values o f  each group, “before therapy ”, compared to values o f  each group, “after 
therapy ” (Wilcoxin Ranks test)
Although patients <12yrs produced significantly less PPD-induced IFN-y compared to 
controls < 12yrs “after therapy” (p = .024), no significant differences were found between 
any of the groups “before therapy” and “after therapy”.
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5.3.2 IL-2 Production
5.3.2.1 IL-2 production after PHA stimulation
Day 3 PHA-stimulated IL-2 production from diluted whole blood from TB patients and 
healthy Mantoux positive controls according to age group, “ before therapy” and “after 
therapy”. Data are represented as box plots showing the median and extending to the 25th and 
75th percentiles. The lines extending from the box extend to upper and lower adjacent values.
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Table 5.6
Median (interquartile range: IQ) of IL-2 in pg/ml after stimulation of whole blood with PHA 
(lOjag/ml) for TB patients and their age-related healthy Mantoux positive controls (<12 yrs or 
>12 yrs) “before therapy” (at TB diagnosis), and “after therapy” (approximately 1 year later)
“Before therapy” “After therapy”
n Median
(IQ)
p - , 
value
n Median
(IQ)
P- ,
value
p - 2 
value
pts <12 years 15 172
(44-220) .246
15 86
(61-305) .939 .691
con <12 years 22 194
(67-340)
22 106
(49-282) .263
pts >12 years 12 88
(48-153) .004
12 276
(157-513) .287 .010
con >12 years 19 474
(136-660)
19 174
(40-436) .398
Total 68 184
(68-325)
68 158
(61-322) .869
p-value1: Values o f  patients <12 yrs compared to values o f  controls <12 yrs and values o f  
patients >12 yrs compared to values o f controls >12 yrs (Mann-Whitney U test) 
p-value2: Values o f  each group, “before therapy”, compared to values o f each group, “after 
therapy ” (Wilcoxin Ranks test)
Patients >12 yrs, who produced significantly less PHA-stimulated IL-2 compared to controls 
>12 yrs, “before therapy” (p = .004), subsequently produced significantly more IL-2 “after 
therapy” compared to before therapy (p = .010).
When the values of all patients (n = 27) were analysed, PHA-induced IL-2 production was 
significantly higher “after therapy”, compared to “before therapy” (p = .029). (data not shown 
on table).
No other significant differences between values “before therapy” and “after therapy” were 
found between any of the groups.
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5.3.2.2 IL-2 production after PPD stimulation
Day 3 PPD-stimulated IL-2 production from diluted whole blood from TB patients and 
healthy Mantoux positive controls according to age group, “ before therapy” and “after 
therapy”. Data are represented as box plots showing the median and extending to the 25th and 
75th percentiles. The lines extending from the box extend to upper and lower adjacent values.
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Table 5.7
Median (interquartile range: IQ) of IL-2 in pg/ml after stimulation of whole blood with PPD 
(3.3jj.g/ml) for TB patients and their age-related healthy Mantoux positive controls (<12 yrs 
or >12 yrs) “before therapy” (at TB diagnosis), and “after therapy” (approximately 1 year 
later)
“ Before therapy” “After therapy”
n Median
(IQ) P'  i value
n Median
(IQ)
p - , 
value value2
pts <12 years 15 102
(71-371) .191
15 ~ in
(21-152) .915 .031
con <12 years 22 305
(106-402)
22 104
(45-162) <.001
pts >12 years 12 65
(10-151) .527
12 49
(30-120) .287 .638
con >12 years 19 98
(26-267)
19 87
(30-176) .295
Total 68 126
(47-327)
68 90
(36-152) <.001
p-value': Values o f  patients <12 yrs compared to values o f  controls <12 yrs and values o f  
patients >12 yrs compared to values o f  controls >12 yrs (Mann-Whitney U test) 
p-value2: Values o f  each group, “before therapy”, compared to values o f  each group, “after 
therapy” (Wilcoxin Ranks test)
Generally, all PPD-induced IL-2 values were lower “after therapy” compared to “before 
therapy”, but only patients and controls < 12yrs produced significantly less IL-2 “after 
therapy” (p = .031 and p  < .001 respectively) compared to “before therapy”.
When the values of all controls (n = 41) were analysed, PPD-induced IL-2 production was 
significantly lower “after therapy”, compared to “before therapy” (p <.001). (data not shown 
on table).
In addition, when values of all samples, were compared “before therapy” and “after therapy”, 
values “after therapy” were significantly less than values “before therapy” (n = 68; p  <.001).
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5.3.3.1 TNF-a production after PHA stimulation
Day 3 PHA-stimulated TNF-a production from diluted whole blood from TB patients and 
healthy Mantoux positive controls according to age group, “ before therapy” and “after 
therapy”. Data are represented as box plots showing the median and extending to the 25th and 
75th percentiles. The lines extending from the box extend to upper and lower adjacent values.
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Table 5.8
Median (interquartile range: IQ) of TNF-a in pg/ml after stimulation of whole blood with 
PHA (10|a,g/ml) for TB patients and their age-related healthy Mantoux positive controls (<12 
yrs or >12 yrs) “before therapy” (at TB diagnosis), and “after therapy” (approximately 1 year 
later)
“Before therapy” “After therapy”
n Median
(IQ)
P-
value1
n Median
(IQ) P~ i value value2
pts <12 years 13 234
(56-434) .428
13 172
(141-468) .271 .600
con <12 years 22 313
(150-575)
22 142
(94-353) .014
pts >12 years 12 222
(156-420) .001
12 573
(286-961) .236 .004
con >12 years 19 632
(360-1110)
19 427
(167-684) .004
Total 66 343
(194-625)
66 270
(136-569) .095
p-value1: Values o f  patients <12 yrs compared to values o f controls <12 yrs and values o f 
patients >12 yrs compared to values o f  controls >12 yrs (Mann-Whitney U test) 
p-value2: Values o f  each group, “before therapy”, compared to values o f each group, “after 
therapy” (Wilcoxin Ranks test)
“Before therapy”, patients >12yrs produced significantly less TNF-a in response to PHA than 
controls >12yrs (p = .001). These patients subsequently produced significantly more TNF-a 
“after therapy” compared to “before therapy” (p = .004). However, controls < 12yrs and > 
12yrs produced significantly less TNF-a “after therapy” compared to “before therapy” (p = 
.014 and p  = .004 respectively).
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5.3.3.2 TNF-a production after PPD stimulation
Day 7 PPD-stimulated TNF-a production from diluted whole blood from TB patients and 
healthy Mantoux positive controls according to age group, “ before therapy” and “after 
therapy”. Data are represented as box plots showing the median and extending to the 25th and 
75th percentiles. The lines extending from the box extend to upper and lower adjacent values.
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Table 5.9
Median (interquartile range: IQ) of TNF-a in pg/ml after stimulation of whole blood with 
PPD (3.3|j.g/ml) for TB patients and their age-related healthy Mantoux positive controls (<12 
yrs or >12 yrs) “before therapy” (at TB diagnosis), and “after therapy” (approximately 1 year
later)
“Before therapy” “After therapy”
n Median
(IQ)
p- , 
value
n Median
(IQ)
P' i value
P- 2
value
pts <12 years 13 109
(34-207) .699
13 60
(31-88) 1.000 .055
con <12 years 22 121
(46-154)
22 56
(33-80) .006
pts >12 years 12 116
(95-255) .101
12 55
(27-74) .306 .006
con >12 years 19 97
(10-150)
19 43
(29-55) .036
Total 66 109
(10-172)
66 52
(31-73) <.001
p-value1: Values o f  patients <12 yrs compared to values o f controls <12 yrs and values o f  
patients >12 yrs compared to values o f  controls >12 yrs (Mann-Whitney U test) 
p-value2: Values o f each group, “before therapy”, compared to values o f  each group, “after 
therapy ” (Wilcoxin Ranks test)
Generally, all PPD-induced TNF-a was lower “after therapy” compared to “before therapy”. 
Values for all groups, “before therapy”, compared to “after therapy”, were significantly 
lower, except for patients < 12yrs, whose values fell just short of reaching statistical 
significance (p = .055).
When the values of all patients (n = 25) was analysed, PPD-induced TNF-a production was 
significantly lower “after therapy”, compared to “before therapy” (p =.001). When the values 
of controls (n = 41) was analysed, PPD-induced TNF-a production was also significantly 
lower “after therapy”, compared to “before therapy” (p =.001). (data not shown on the table)
In addition, values for all samples, “after therapy” were significantly lower than values for all 
samples, “before therapy” (n = 66; p  <.001).
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5.4.1 Lymphocyte proliferation studies
As discussed previously, proliferation assays assess the proliferative capacity of T cells in 
response to a particular mitogen or antigen. The majority of studies in the literature report on 
immune responses of TB patients at diagnosis. Generally, these studies have reported lower 
proliferative responses in TB patients compared to healthy sensitised controls. Few studies 
have been performed in which these responses have been re-assessed after completion of TB 
therapy. Of the few that have been reported, most of them report restoration of proliferative 
responses in TB patients after therapy, compared to before therapy. Diele et al., (2000) report 
an increase in PPD-induced proliferative responses in 14 out of 16 children after TB therapy. 
Similarly, Onwubalili et al., (1985) report an increase in proliferative responses in response to 
PPD stimulation in 9 out of 9 adults while Torres et al., (1998), found an increase in 
proliferative responses after therapy in 4 out of 7 adults after stimulation with the 30kDa 
antigen of M. tuberculosis. A more recent report of Portales-Perez et al., (2002), using a non­
radioactive proliferation assay, reported no significant differences in proliferation in response 
to mycobacterial antigens, at diagnosis of TB patients compared to healthy sensitised 
controls, nor after completion of TB therapy. They speculate that the use of a non-radioactive 
assay (that detects the number of viable cells) was not an efficient manner of detecting 
lymphocyte reactivity in human PBMC cultures.
In this study, values for PHA-induced proliferative responses for TB patients > 12yrs, which 
were significantly lower than controls “before therapy”, showed an increase “after therapy”, 
but the difference was just short of achieving statistical significance. PPD-induced 
proliferative responses for TB patients > 12yrs were also significantly lower than controls 
“before therapy”, and also demonstrated an increase “after therapy”, but this time the 
difference was statistically significant. Interestingly, values for controls <12 yrs and > 12yrs 
were significantly lower “after therapy” compared to “before therapy”, after PPD stimulation. 
This finding may be due to the fact that the “before therapy” assays were performed 
approximately a year earlier by a different investigator.
A possible reason for the restoration of proliferative responses in TB patients “after therapy” 
could be that antigen-responsive T cells, which were sequestered at the site of disease during 
active TB infection, could have recirculated into the bloodstream. Also, the levels of
5.4 Discussion
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immunosuppressive cytokines such as TGF-P and IL-10, which have been shown to be 
increased in TB patients with active disease, have been reported to be lower after TB therapy 
(Hirsch et al., 1999b; Garcia et al., 2002; Torres et al., 1998).
The findings in this study generally agree with those in the literature that proliferative 
responses of patients (in older children and adults in this study) are increased after TB 
therapy, compared to before therapy.
5.4.2 Cytokine studies
Note: IL 10 values “before therapy” could not be directly compared to levels “after therapy” 
as the Genzyme Duoset ELISA kits, used in the “before therapy” study, were not available 
anymore at the time when the “after therapy” study was performed.
5.4.2.1 IFN-y production
The assessment of immune responses, specifically the measurement of cytokine production, 
in TB patients compared to healthy sensitised controls has often been previously reported. 
These studies have generally reported depressed production of IFN-y in TB patients 
compared to controls. Very few studies have followed up these patients and re-assessed 
immune responses after TB therapy. Hirsch et al., (1999b) report that PPD-induced IFN-y 
production from PBMCs of TB patients, which was depressed before TB therapy, showed a 
slight increase, but remained significantly lower than control values, one year after therapy. 
Turner et al., (2000) showed an increase in the production of IFN-y after stimulation with M. 
bovis BCG after therapy, compared to values found before therapy. Verbon et al., (1999) 
measured serum cytokine levels in TB patients before, during and after TB therapy. They 
reported significantly higher levels of IFN-y in TB patients compared to healthy sensitised 
controls, before therapy. These levels showed a decline during therapy and a further decline 
after therapy, when they were no longer significantly different to the healthy controls. 
Portales-Perez et al (2002), after PBMC stimulation with the 30kDa antigen of M. 
tuberculosis, did not find any significant differences between TB patients before and after TB 
therapy.
In this study, all values for PHA- and PPD-induced IFN-y for patients as well as controls 
were generally increased “after therapy”, compared to “before therapy”. A possible
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explanation for the increase in IFN-y production in all subjects may be the due to the 
increased capacity of the immune system to produce this cytokine as all subjects would be 
one year older when the “after therapy” study was performed and the immune system would 
be more “mature”.
The findings in this study do not conclusively show that IFN-y concentrations in TB patients 
improve after therapy.
5.4.2.2 IL-2 production
Studies in the literature generally report a diminished production of Thl cytokines (IFN-y and 
IL-2) in newly diagnosed TB patients compared to healthy controls (Hirsch et al., 1995; 
Zhang et al., 1995 Torres et al., 1994). Very few studies have re-assessed immune responses 
after completion of TB therapy and studies reporting on IL-2 production in TB patients, after 
TB therapy, are very rare. One report, using a flow cytometric technique, did not find any 
PPD-induced IL-2 production from peripheral blood lymphocytes before or after therapy, 
although they did measure PPD-induced IL-2 in cells from bronchoalveolar lavage fluid. 
Hirsch et al., (1999a) measured M  tuberculosis -induced IL-2 responses in TB patients and 
healthy sensitized controls, before therapy and 6 months after therapy. They found 
significantly lower IL-2 values in patients compared to controls, before therapy. After 
therapy, IL-2 levels in patients increased to levels comparable to those of healthy controls.
Patients >12 years produced significantly more PHA-induced IL-2 “after therapy” compared 
to “before therapy”. In this study, values for PHA- and PPD-induced IL-2 were generally 
lower “after therapy” compared to “before therapy” (except for patients >12 years after PHA 
stimulation). Both patients as well as controls < 12 years produced significantly less PPD- 
induced IL-2 “after therapy” compared to “before therapy”.
The general depression of IL-2 values, “after therapy” compared to “before therapy”, is 
unusual and will be further commented on in the general discussion.
5.4.2.3 TNF-a production
Studies on TNF-a production in TB patients (before TB therapy) compared to healthy 
sensitised controls, have reported TNF-a to be increased in TB patients compared to controls
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(Dlugovitzky et al., 2000), or have demonstrated no significant differences between TB 
patients and healthy controls (Portalez-Perez et al., 2002; Schwander et al., 1998; Hirsch et 
al., 1996). Only one of the latter studies reports on TNF-a production after TB therapy. They 
report that TB patients produced significantly more TNF-a after stimulation with the 30kDa 
antigen of M.tuberculosis, 8 months as well as 12 months after the commencement of therapy 
compared to before commencement of therapy.
Patients >12 years produced significantly more PHA-induced TNF-a “after therapy” 
compared to “before therapy”. Values for all other groups were lower “after therapy” 
compared to “before therapy” for PHA- and PPD-induced TNF-a. These differences were all 
significant in all groups except for patients <12yrs (which fell just short of reaching 
significance).
The general depression of TNF-a values, “after therapy” compared to “before therapy”, is 
unusual and will be further commented on in the general discussion.
5.5 Summary
In this section of the study, TB patients were investigated for their proliferative and cytokine 
responses to a mitogen (PHA) and a specific mycobacterial antigen (PPD) before and after 
commencement of TB therapy.
After PHA-stimulation, patients <12 years generally did not show any differences in 
responses before and after TB therapy, except for an increase in IFN-y production. Patients 
>12yrs demonstrated improvement in all PHA-induced proliferative and cytokine responses 
“after therapy”, compared to “before therapy”.
After therapy, patients <12 years demonstrated decreased PPD-induced IL-2 and TNF-a 
production, compared to before therapy. Patients >12yrs demonstrated improvement in PPD- 
induced-induced proliferation, but decreased production of TNF-a, after therapy, compared 
to before therapy.
Except for IFN-y production, all proliferative and cytokine responses for controls (<12 years 
and >12 years) were generally lower after therapy, compared to before therapy.
Stellenbosch University http://scholar.sun.ac.za/
118
CHAPTER 6 
GENERAL DISCUSSION AND CONCLUSIONS
The first aim of this study was to optimise a whole blood assay for the assessment of 
proliferative and cytokine responses in response to a mitogen (PHA) and a specific 
mycobacterial antigen (PPD). There are many advantages of whole blood assays and these 
have already been discussed in the introductory chapters. In addition, results of whole blood 
assays and that of conventionally used PBMCs have been shown to be comparable (Elsasser- 
Beile et al., 1995; Yaqoob et al., 1999). One may wonder how the results of whole blood 
assays can be directly compared to that of PBMCs when it is not known exactly how many 
white blood cells are present in each well of the culture plate in the whole blood assay. This 
issue is of even greater importance when comparing in-vitro immune responses between 
children and adults, as it is known that age-related differences in white blood cell counts per 
volume of whole blood exist. Elsasser-Beile et al., (1995) as well as Scholvinck (2001) in the 
initial “before therapy” part of this study normalised their whole blood assay cytokine results 
to the blood samples’ initial absolute amount of mononuclear cells and found results to be 
comparable.
In our laboratory, the whole blood assay proved to be a technically simple, non-laborious 
assay that, according to the literature, produces results that seem to correlate well with that of 
conventionally used PBMCs.
The major shortcoming of studies of this kind, where immune responses in TB patients are 
measured from peripheral blood or its components, is that it may not be representative of the 
actual events at the site of disease. It has previously been documented that different balances 
of cytokines within the same patient can be seen when bronchoalveolar lavage cells or pleural 
fluids are compared to cells from peripheral blood (Schwander et al., 1998; Barnes et al., 
1993). It can thus be argued that the measurement of peripheral responses would not provide 
accurate information on the pathogenisis of TB disease in humans. However, in studies of 
this kind, it is more difficult to obtain bronchoalveolar or pleural fluids from patients. In 
addition, this study was performed approximately one year after TB diagnosis, by which time
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antigen specific cells, that may have been sequestered at the site of disease, would have re­
circulated into the periphery.
Another issue to be in mind is the inter- and intra-individual variations in cytokine 
measurements that are known to occur. One limitation of this study is that it did not address 
this issue, but Yaqoob et al., (1999), who also found significant inter-individual variation in 
cytokine production, demonstrated that the level of cytokine produced appeared to be 
characteristic of an individual.
Diurnal variations of levels of serum cytokine levels in healthy individuals are also known to 
occur (Petrovsky et al., 1995). All blood samples were taken between 9 and 12am and 
processed within 2-3- hours in order to minimise this variation.
The measurement of cytokines by ELISA is a standard assay and is usually reliable and 
reproducible and was thus also used for the measurement of cytokine concentrations in this 
study. Variations in laboratory conditions is an important factor that can influence the 
outcome of ELISA results and thus rigid quality control measures, such use the of internal 
reference controls and inter- and intra-assay studies, are essential. In this study, the cytokine 
standard served as the internal reference control and was also used for the inter-assay 
variation studies, which was always well within the required limits (<10% variation).
The second aim of the this study was to determine if there was a relationship between age and 
whole blood PHA- and PPD-induced proliferation and cytokine production in subjects of 
different ages. Neither PHA- and PPD-induced proliferation showed any correlation with age. 
Except for IL-2, age correlated positively with all PHA-stimulated cytokines, namely: IFN-y, 
TNF-a and IL-10. This study is in agreement with reports in the literature as proliferation and 
IL-2 production have previously been reported to have no relationship with age (Lewis el at., 
1996). In addition, IFN-y and TNF-a have previously been reported to be lower in children 
compared to adults (reviewed by Smith et al., 1997). None of the cytokines induced by PPD 
showed any relationship with age. A possible reason for this finding could be that all subjects 
in this study had been exposed to M.tuberculosis and that in itself may have been sufficient to 
generate an in-vitro response, irrespective of age. These findings appear to indicate that the 
nature of the stimulant as well as previous exposure, determines if there is a relationship with
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age. The establishment of normal reference ranges, for individual stimulants, as well as the 
use of age-matched controls in studies such as these, is thus essential. Further studies utilizing 
larger numbers of children and a broader panel of cytokines and stimulants would help to 
address these issues.
The third aim of this study was to compare immune responses of patients after treatment 
(“after therapy”) to data obtained at diagnosis (“before therapy”). In the literature, immune 
responses of TB patients have generally been reported to be depressed at the time of 
diagnosis, with subsequent improvement, after therapy.
In this study, there was a trend towards increased concentrations of PHA- and PPD-induced 
IFN-y for all subjects (patients and controls) “after therapy”, compared to “before therapy”. 
An increase in IFN-y production in TB patients after TB therapy has previously been 
documented in the literature (Turner et al., 2000) however, in this study, controls also 
demonstrated an increase in IFN-y production. This finding could therefore possibly be due to 
a technical variation of the assays (the assays were performed a year apart and by different 
researchers) or due to maturation in the capacity of the immune system to produce IFN-y (but 
this is less likely in subjects older than 12 years of age).
Patients >12yrs demonstrated improvement in all proliferative and cytokine responses 
(except for PPD-induced IL-2 and TNF-a) “after therapy”, compared to “before therapy”. 
These results are in good agreement with other studies showing a restoration of immune 
responses after drug treatment (Diele et al., 2000; Onwubalili et al., 1985; Turner et al., 2000; 
Wilkinson et al., 1998; Hirsch et al., 1996). The cause for the diminished immune response in 
untreated active TB can probably be ascribed to a number of factors, with 
compartmentalization at the site of disease (Barnes et al., 1989; Diele et al, 1999), production 
of immunosuppressive cytokines such as IL-10 or TGF-P (Hirsch et al., 1996) and defective 
antigen presentation (Pancholl et al., 1993) all contributing.
TNF-a and IL-2 values “after therapy” were all generally lower than values, “before therapy” 
(except for patients >12yrs). In addition, except for IFN-y production, all proliferative and 
cytokine responses for controls (<12 years and >12 years) were generally lower after therapy, 
compared to before therapy. A major limitation of the study was that a different researcher
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performed the “before therapy” study. In addition, a significant period of time (approximately 
one year) separated the two studies. These two factors could have been responsible for 
variations in laboratory conditions (for example, reagents and technical proficiency) that 
could have influenced the outcome of these results. Another possible explanation for the 
lower cytokine values found in the “after therapy” study compared to the “before therapy” 
study could be the fact that the Duoset kits had been purchased well in advance and were 
very close their expiry dates when the “after therapy” study was performed and perhaps were 
not as sensitive as they were one year earlier (although this is not likely to be the case as the 
inter-assay variation of the internal reference control was always <10%). No satisfactory 
explanation for this phenomenon could be found. It can perhaps only be ascribed to some 
unknown variation in laboratory conditions. Recommendations for future longitudinal studies 
which measure the production of cytokines by ELISAs would be to try and purchase Duoset 
kits which have a longer shelf life and that, where possible, the same person perform all 
ELISAs. Also, storage of samples so that all ELISAs are performed together would reduce 
any assay variability, provided the stability of the cytokine being measured is satisfactory.
Further studies, investigating these and additional immunologic parameters in TB patients of 
different ages, both before, as well as after TB therapy will provide important information 
regarding the pathogenesis of TB.
In conclusion:
1. The whole blood assay is a simple, non-laborious assay that, according to the literature, 
produces results that seem to correlate well with that of conventionally used PBMCs.
2. Age appears to be an important variable in the quantitative assessment of cellular immune 
responses when the mitogen, PHA is used as a stimulant.
3. Immune responses of older TB patients appear to improve after TB therapy, compared to 
before TB therapy.
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